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Abstract 
The biotin biosynthetic enzyme 8-amino-7-oxonOnaflOate synthase (AONS) from Escherichia coil is an 
homodimeric enzyme and relies on a pyridoxal-5'-phosphate (PLP) cofactor for catalytic activity. 
Specific activity of the over-expressed enzyme is approximately 0.4U at 30°C. To investigate the role of 
residues at the active site on the catalytic mechanism of the enzyme, two separate mutants have been 
created by site directed mutagenesis. H133 lies in parallel with the pyridine ring of the cofactor, and was 
mutated to a phenylalanine residue, with subsequent loss of cofactor binding. Alteration of the lysine 236 
residue crucial for forming an aldimine linkage with the cofactor, to alanine resulted in a reduction, but 
no loss, of cofactor binding. The specific activities of both mutants were reduced by approximately ten- 
fold. 
The corresponding bioF gene from an hyperthermophilic bacterium, Aqufex aeoiicus, was cloned and 
AONS over-expressed in an E.coli host. The enzyme was characterised by a number of biophysical 
techniques. It is a dimer in solution, with a monomeric mass of 42.3 kDa and one active site per subunit 
Specific activity of the purified enzyme was 0.7U at 30°C, and optimum activity occurred at 80°C. The 
heat stable enzyme displays a greater affinity for its PLP cofactor and the binding of the coenzyme on 
mutation of the active site histidine residue corresponding to H133 in E.coli, indicates that PLP is bound 
by a residue not involved in E.coli AONS-PLP binding. Orthorhombic crystals grew in wells containing 
1.6M-2.5M ammonium sulphate at 60°C, which diffracted to 2.94A. Analysis of the diffraction data 
suggested a space group of P2 1 2 1 2 and a large unit cell containing at least 6 subunits in the asymmetric 




A - Angstrom (10' ° metres) 
ADP - Adensosine diphosphate 
AKB - 2-amino-3-oxobutyrate CoA ligase 
ALAS - &-aminolaevulinate synthase 
amp - Ampicilliii 
AMP - Adenosine monophosphate 
AON - 8-amino-7-oxononanoate 
AONS - 8-amino-7-oxononanoate synthase 
ATP - Adenosine 5'- triphosphate 
BCCP - biotin carboxyl carrier protein 
bp -base pair 
BES - (N,N-bis[2-Hydroxyethyl]-2-aminoethane-sulfonic acid) 
Ca 21 - Calcium ion 
CaCI - Calcium Chloride 
CAPS - (3-[Cyclohexyamino]-2-aminoethane-sulfonic acid) 
CO2 - carbon dioxide 
CoA - Coenzyme A 
CoASH - unbound Coenzyme A 
Cs - Caesium 
CsCI - Caesium chloride 
Da - Daltons 
DAN - 7,8-diaminononanoate 
DM15 - 7,8-diaminononanoate synthase 
DNA - deoxyribonucleic acid 
iv 
DTB - Dethiobiotin 
DTBS - Dethiobiotin synthase 
EDTA - ethylene diaminetetraacetic acid 
IPTG - Isopropl ,D-thiogalatopyianoside 
HEPES - (N-[2-Hydroxyethyl]-piperazine-N'-[2'-ethansulfonic acid]) 
HPLC - High pressure liquid chromatography 
K - Kelvin (-273°C) 
K - Potassium ion 
KCI - Potassium chloride 
K2HPO4 - Dipotassium phosphate 
K142PO4 - Potassium diphosphate 
Kb - kilobases 
kDa - kilodaltons 
LB - Luria Bertani medium 
M - molar 
- microlitres (lO) 
ml - millilitres (10) 
gM - micromolar (10) 
mM - millimolar (10) 
mol - moles 
Mg2 - Magnesium ion 
MgCl2 - Magnesium chloride 	- 
Na - Sodium ion 
NaCl - sodium chloride 
NAD - Nicotmamide adenine dinuclotide 
NADH - reduced form of Nicotinamide adenine dinuclotide 
V 
NADP+ - Nicotinamide adenine dinuclotide phosphate 
NADPG - reduced form of Nicotmamide adenine dinuclotide phosphate 
NaBH4 - Sodium borohydride 
NCS - Non-crystallographic symmetry 
NTP - Nucleotide triphosphate 
ng - nanograms (10) 
(NH4)2SO4 - Ammonium sulphate 
nm - nanometres (10) 
OD - Optical density 
PCR - Polymerase Chain Reaction 
PEG - Polyethylene glycol 
PLP - Pyridoxal-5'-phosphate 
rpm - revolutions per minute 
RNA - ribonucleic acid 
RT - Room temperature 
S-AdoMet - S-adenosyl methionine 
SDS PAGE - Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SPT - Serine palmitoyl transferase 
TAE - Iris acetate EDTA 
TCA - Trichloroacetic acid 
TFA - Trifluoroacetic acid 
Tris - Tris [hydroxymethyl] ammomethane 
UV/vis - Ultraviolet/visible 
wi-wild type 
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Chapter 1 
Introduction to Biotin 
Biosynthesis 
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1.1 Biotin 
Biotin, a water-soluble vitamin, is an essential cofactor for the transportation of an activated carboxyl 
(CO2) group in biological carboxylase, decarboxylase and transcarboxylase reactions (1-3). The three 
different reactions are classified into classes I, II and III. 
NHNH 
H.4- 3 H 
2\ OOH 
Figure 1.1.1 
The absolute configuration of biotin was elucidated in 1966 (4) using x-ray crystallography. An 
imidazolone (ureido) ring is cis fused to a tetrahydrothiophene ring, substituted at position 2 by a 
valeric acid moiety. 
Carboxylase reactions, termed class I reactions, require ATP and use bicarbonate as the carboxyl 
source (1) Possibly the best studied of this group is acetyl-CoA carboxylase (EC 6.4.1.2), an enzyme 
involved in fatty acid synthesis with an essential requirement for biotin. In E.coli, the formation of 
malonyl-CoA from acetyl-00A is catalysed by three protein components of this enzyme. Biotin is 
anchored via its valeric acid side chain to the s amino group of a lysine residue of the Biotin 
Carboxyl Carrier Protein (BCCP). The length of the linkage allows rotational freedom for the 
cofactor. Biotin is carboxylated at the imidazolone (ureido)-N' in two steps. First, carboxybiotin is 
formed at the expense of ATP at the active site of biotin carboxylase. The activated carboxybiotin 
group is then transferred to the active site of the carboxytransferase component and proton 
abstraction occurs at imidazolone-N 3 (5) The resulting intermediate reacts with acetyl-CoA, causing 
transfer of the carboxyl group to produce malonyl-CoA. Class H reactions are catalysed by 
decarboxylases and are not ATP dependent. They occur in anaerobic prokaryotes and include sodium 
transport channels The third class of biotin-dependent reactions, class III, are catalysed by 
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transcarboxylases. This type of reaction does not require ATP is unique and proceeds on two separate 
subunits of the same enzyme, catalysing fermentation of propionic acid in propionii-bacteria (see 
table I) (6) 
Animals are unable to produce biotin themselves, and must rely on either dietary sources, such as 
liver, kidneys, legumes and nuts, or microorganisms within the gut flora. Biotin deficiency in 
animals can cause intra-muscular and immune disorders and signs include alopecia, dermatitis and 
pernicious anaemia (7). Should such a deficiency be diagnosed, biotin is also commercially available 
as vitamin H (or 13 8) (6) which is especially important as an additive to animal foodstuffs (8). 
Biotin is also useful as a biotechnology probe (9). One of the strongest protein-ligand interactions 
known (KlO' 5M) is that of biotin with the tetrameric 70kDa egg white protein avidin (10-I1). 
Each subunit is folded into an 8-stranded 13-barrel and biotin binds at one end of this barrel, in a 
pocket between two tryptophan (12). This phenomenon has been harnessed and used as a tool for 
biochemical research. The interaction is also being used as a model for investigating macromolecule- 
ligand binding. 
Although biotin is commercially significant, the shortest synthetic route for vitamin production 
consists of 12 chemical steps (Hoffmann-La Roche synthesis). In contrast, the natural enzymes of the 
biotin operon in Escherichia coli achieve this conversion in only four steps from pimeloyl-CoA via 
proteins encoded by the genes bioF, bioA, bioD and bioB. An attractive aim would be to produce this 
molecule biologically, but if future commercial production is to be directed by microbial 
fermentation, the biosynthesis of biotin must be fully understood and characterised. 
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Class 
	 Enzyme 
	 Physiological role 
Class I: Carboxylases 	 Acetyl-CoA carboxylase 	 Gluconeogenesis, lipogenesis 
Pyruvate carboxylase 
	 Fatty acid biosynthesis 
MI. 
Enz-biotin + ATP + HCO3• 	Enz-biotin-CO, + ADP + P 1 + 
Enz-biotin-CO + R-H 	Enz-biotin + R-0O2 
Class II: Decarboxylases 
Enz-biotin + R.0O2 	Enz-biotin-CO + R-H 
Enz-biotin-0O2- + 2(Na 	 Enz-biotin + HCO, + 2(NaC)o,g 
Class III: Transcarboxylases 
Enz-biotin + oxaloacetate 	Enz-biotin-CO + pyruvate 
Enz-biotin-CO + propionyl-CoA 	Enz-biotin + methy!malonyl-CoA 
Propionyl-CoA carboxylase 






Catabolism of odd numbered fatty acids an 
amino acids lie; Thr; Met; Val 
Leucine catabolism 
Isoprenoid catabolism in bacteria 
Urea catabolism in ureasi urea autotrophs 
Final step in anaerobic lactate fementation 
Inducible enzyme in certain citrate autotrophs 
Fermentation of propionic acid in 
Propioniibacteria 
Table 1.1 
Biotin dependent enzymes 
Page 4 
e(aftte I: twdactiog to &otia &04e414 
1.2 Biotin Biosynthetic Pathway 
Biotin is produced in minute quantities in nature and the biosynthetic pathway consists of similar 
enzymes in fungi (13), bacteria (14-15) and higher plants (6) (16-17). It is thought that a maximum 
of only 1000 molecules of biotin is present at any one time in the cells of E.coli (18) and 
concentrations do not generally exceed nanomolar quantities in bacteria (6). In contrast, biotin in 
concentrations up to 11.tM may be found in the cytosol of plant mesophyll cells (19). 
Discovered as the result of cross-feeding and deletion mapping experiments (14) (18) the four step 
synthesis in E. coli involves enzymes encoded by the genes bioF, bioA, bioD and bloB found on the 
bio operon at 17 mm, lying between the attachment site of the X phage (Aatt) and the uvr gene, on 
the bacterial genome (20-2 1). 
ORFJ 	bioA 
Aar
bioB 	bioF 	bloC bioD 
uvrB 
Figure 1.2.1 	
PB 	 PA 
The biotin operon found at 17 min on the E.coIi genome. Transcription of b1oBFCD is promoted to the 
right while bioA transcription takes place on the complementary DNA strand. Partially overlapped 
face-to-face promotors initiate this divergent transcription. This is a cartoon representation and gene 
sizes are not drawn to scale. 
Two further genes, bloC, also found on the operon, and bioH, a separate gene at 74mm (22) encode 
enzymehieh have been implicated in the synthesis of pimeloyl-CoA. The sequences of the genes 
of the biotin operon were determined by Otsuka and co-workers in 1988 (23), and the stop codons 
and initiators of each gene on the operon were found to overlap. The biotin operon, bioABFCD, is 
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divergently transcribed (24) with the promotor and operator sites OPA and OPB contained in a 40 
nucleotide imperfect palindrome between bioA and bioB (25). There is also an open reading frame 
downstream of bioA, ORFI, the function of which remains unknown. 
A biotin operon, similar to that which exists in E.coli, is also found in other gram negative 
facultative anaerobes such as Erwinia herbicola (26), Serratia marcescens (27), Citrobacterfreundii 
and Salmonella typhumurium (28). In a further gram negative bacterium, Xylella furiosa, however, 
the biotin genes are scattered throughout the genome (29). Gram positive bacteria, of which Bacillus 
sp. is the most widely studied, display a different clustering of these enzymes. Bacillus subtillis also 
has a single biotin operon. This is transcribed in one direction only and contains the genes 
b1oWAFDBI and an ORF2 downstream of biol, which appears to encode a P450-like enzyme not 
apparently essential for biotin synthesis (30). There are, however, two bio gene clusters contained on 
the Bacillus sphaericus genome (31). The first operon, bioDAYB contains the genes encoding the 
enzymes for the final steps in biotin biosynthesis and a gene, bioY, coding for a protein of unknown 
function. The second cluster contains three biotin genes, bioXWF. The first, bioX, encodes a protein 
of unknown function, whilst the bioW and bioF proteins together can complement an E.coli strain 
deficient in bioC and bioH on addition of pimelate, suggesting bioW is involved in the synthesis of 
pimeloyl-CoA. In Brevibacterium flavium, there is no bioF gene and bioA and bioD are situated on 
unlinked chromosomes (32). Saccharomyces cerevisiae also has biotin synthetic genes located on 
different chromosomes. The extremely thermostable bacteria Aqufex aeolicus has biotin genes 
similar to Bacillus sp. They are not, however, clustered in an operon, but are found scattered 
throughout the genome (33). 
Synthesis of pimeloyl-CoA varies within different bacterial and plant hosts, and different species 
have various clustering of the genes. B.sphaericus and A.aeolicus catalyse the synthesis of this 
chemical by expressing bioW which converts pimelic acid into pimeloyl-CoA. This protein is not 
present in E.coli and current consensus is that the BloC and BioH proteins are involved in pimeloyl-
CoA synthesis. Pimeloyl-00A is also synthesised in plants from piinelic acid (16). Experiments 
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conducted with biotin genes in an E.coli host suggest that it is this step which may prove limiting to 
biotin production (34). The four main steps of biotin biosynthesis and the method of biotin 
repression, however, are generally conserved across the organisms synthesising this chemical. They 
have been best characterised in E. coli. 
1.2.1 8-Amino-7-oxonOflaflOate Synthase (AONS) 
The first committed enzyme in the biosynthetic pathway of E. coli, 8-amino-7-oxononoate synthase 
(EC 2.3.1.47) is the product of the bioF gene. It has an essential requirement for the versatile 
cofactor pyridoxal-5'-phosphate (PLP), and catalyses the decarboxylative condensation of L-alanine 
and pimeloyl-CoA to yield 8-amino-7-oxononaflOate (AON). Only L-alanine may act as a substrate 
for AONS (35) and its stereoisomer, D-alanine, is an inhibitor (36). 
H3N 




CO2- 	 He)---~CO2H 
pimeloyl CoA 	 L-alanine 	 8-amino-7-oxononanOate 
Figure 1.2.2 
The stereospecific carboxylative condensation of L-alanine and pimeloyl-CoA 
Although the enzyme was initially purified by Eisenberg and co-workers in the 1970's (14), the exact 
sequence of the E.coli bioF gene was only elucidated more than a decade later (23). More recent 
research into the mechanism of AONS from E.coli (36-37) and B.sphaericus (38-39), has shown that 
the holoenzyme is formed by attachment of the PLP cofactor C 4 group via a Schiff base linkage to the 
side chain of a lysine residue in the AONS active site. On addition of L-alanine, an external substrate 
aldimine is formed with PLP. Abstraction of the substrate C a  proton results in formation of the first 
quinonoid of the reaction. Rotation around the Ca  proton (36) confers the correct orientation of the 
intermediate for nucleophillic attack upon the thioester bond of the pimeloyl CoA, releasing CoASH 
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and forming a -ketoacid intermediate. Subsequent decarboxylation results in a second quinonoid 
intermediate. A proton derived from the solvent attacks at C 8  of the a-oxoamine quinonoid (39) prior 
to formation of the external product aldimine. The product is displaced from the cofactor by the 
initial lysine residue and 8amino-7-oxonOnaflOate is released (see fig 1.2.3). 
This mechanistic route places AONS as a member of the family of x-oxoamine synthases (40). The 
three other enzymes of this family are: ö-aminolaevulinate synthase (ALAS: EC 2.3.1.37), a protein 
catalysing the initial step of haem biosynthesis (41-42); serine palmitoyl transferase (SPT: EC 
2.3.1.50), a membrane bound protein involved in the initial stage of sphingolipid biosynthesis (43) 
and 2amino-3-oxobutYrate CoA ligase (AKB: EC 2.3.1.29), an enzyme involved in the threonine 
biosynthetic pathway (44). ALAS is found in non-plant eukaryotes and is encoded by two separate 
genes. Both proteins function as homodimers and one is a housekeeping, hepatic form, whilst the 
other is an erythoid-specific form. It is mutations in this latter form that have been implicated in 
causing sideroblastic anaemia in humans and the mechanism of this enzyme has been extensively 
studied (42) (45-52) but no structure is currently available. SPT is also a eukaryotic enzyme and it is 
suggested that the two separate proteins LCB1 and LCB2 interact to form a heterodimer. A third 
protein, Tsc3 (53) appears to enhance catalytic activity. All four enzymes catalyse the 
decarboxylative condensation of an amino acid and an acyl-CoA. 
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Proposed mechanism for the reaction (red) catalysed by AONS. Residues thought to be involved in 
catalysis are coloured blue (36). UV/visible wavelengths of the various intermediates are shown in 
green. 
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The structure of this protein in E.coli (37) confirms that AONS functions as a homodimer, each 
monomer of which has a mass of 41,464 Da and is composed of three distinct domains. The active 





The crystal structure of AONS (P08: 1 BSO) from E.coli was resolved to 1.65A. (37) with a space 
group P3 1 12. The small N-terminus (blue) attaches close to the active site via a loop to the major 
domain (red). The C-terminal domain is shown in yellow. 
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The AONS enzyme houses the PLP binding lysine (K236) within a deep cleft, which allows space for 
the pantothenic arm of the pimeloyl-CoA substrate to be admitted. A small N-terminal domain is 
linked to a larger central (major) domain which is composed of a seven-stranded n-sheet, of which 
one sheet is antiparellel to the others - a motif common to all PLP dependent enzymes (Ill). The 
sheet is flanked by two a-helices, and curved about two more. The C-terminal domain is 
approximately 100 residues in size. The structure of the holoenzyme shows that there is a 
conformational change upon PLP binding, evidence that is supported by the observation that AONS 
slowly loses its cofactor over time. An active site histidine residue (1-1133) moves to lie in a parallel 







Fig urel .2.5 
Active site of Ecoli AONS. The apoenzyme is represented in the right hand image and the H133 
residue is located away from the centre of the site. H133 swings through 180 0 on binding of the PLP 
cofactor (left hand image) to lie in parallel with the pyridine ring. The image was created in Moiscript. 
This cofactor is stabilised by hydrophobic interactions with His] 33 and co-ordinated further by main 
chain nitrogen atoms of Gly108, Ser107, which are hydrogen bonded to the phosphate tail of PLP. 
The hydroxyl groups of Thr233 and a threonine (Thr266) residue in the opposite monomer are also 
I 
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co-ordinated to the pyridine ring and phosphate tail of the cofactor. Studies of the product (AON) 
bound protein at 2A reveal that there is a rotation of the pyridine ring of approximately 15 0  with 
respect to that for the internal aldimine. There is significant conformational change of the C-
terminal domain of the protein on binding the product. The final turn of the helix is unwound and 
the tip of this flexible domain moves a maximum of S.SA to emulate a lid closure on the external 
product aldimine (36). 
The motif GXGXGG has been suggested as a putative phosphate binding site (45). Structural studies 
of E.coli AONS have shown that this motif is located too distant from the phosphate tail of the PLP 
cofactor to act in this manner. Instead, the motif appears to stabilise dimer interactions and the loop 
on which the crucial Lys236 cofactor binding residue is found. 
The fold of this enzyme is related to both subgroups 1 and 11 (54) aminotransferases (see section 
1.3.2), however, it shares highest fold homology with dialkylglycine decarboxylase (55), a protein 
belonging to subgroup II. Another member of this structural subgroup is 7,8-diaminonanoate 
synthase, which catalyses the second reaction of the biotin biosynthetic pathway (see section 1.2.2). 
A recent re-classification by Grishin (56) places AONS and the ct-oxoamine synthase family in fold 
type I, aminotransferase class II. 
1.2.2 7,8-Diaminononanoate Synthase (DANS) 
The bioA gene encodes the protein 7,8-diaminononanoate synthase (EC 2.6.1.62) which catalyses 
the second step of biotin biosynthesis. Like AONS, it has an essential requirement for the vitamin B 6 
derived cofactor, PLP. The reaction utilises the product of the AONS catalysis, 8-amino-7-
oxononanoate, and involves transamination of an amino group from an S-adenosyl methionine (5-
AdoMet) donor, an as yet unique role for this molecule. The reaction is thought to occur via a ping-
pong mechanism (23), (57) and 5-AdoMet binding is competitively inhibited by the AON substrate. 
Although the initial step of the reaction involves the formation of an AdoMet-PLP imine followed by 
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the transfer of the amino group to AON, little is known about subsequent intermediates of the 
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The conversion of 8-amino-7-oxononaflOate to 7,8 diaminononanoate. 
First purified by Izumi and colleagues in 1972 (35) and subsequently by Stoner and Eisenberg three 
years later (14), initial studies suggested that DANS was dimeric with an essential requirement for S-
AdoMet as the amino donor, since analogues of this compound proved inactive (58). The 
homodimeric nature of this enzyme was proved two decades later when Mick and co-workers 
crystallised and then solved the structure of DANS (59). 
Each monomer of DANS has a mass of 47,000 Da and is composed of two domains. The large 
domain consists of the central residues of the polypeptide and as a 7 stranded, predominately parallel 
13-sheet, surrounded by cc-helices. The small domain is split into two, one moiety lying either side of 
the large domain. 
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Figure 1.2.7 
The structure of DANS (PDB: I OTY) was resolved to 1.8A (59). This structure was also been solved 
by Alexeev et a!, 1999 (unpublished). With a fold similar to the previous enzyme in the pathway, the 
small N-terminal region is shown in blue, the major domain in red and the carboxy terminus in yellow. 
The active site is located in a cleft formed by both domains of one monomer, and residues from the 
large domain of the opposite subunit. The PLP cofactor is located at the bottom of the cleft, and the 
phosphate group interacts with several residues, including a serine group. anchoring a phosphate 
oxygen to both main and side chain atoms. AON is bound with its polar head group towards the 
cofactor, and the carboxyl tail close to the entrance of the active site cleft. This orientation prevents 
AON itself acting as an amino donor. 
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The fold of this PLP dependent aminotransferase is similar to that first observed in aspartate 
aminotransferase (EC 2.6.1.1) (60) and places it in the group of Type I aminotransferases (61). 
DANS belongs to subgroup 11 together with ornithine aminotransferase (EC 4.1.1.17) (62), with 
which it shares highest sequence homology, and dialkyiglycine decarboxylase (EC 4.1.1.64) (55), an 
enzyme which also shares high structural similarity with AONS. 
It has been suggested that the bioA gene is evolutionarily related to the bioF 
gene (23) as the two 
biotin enzymes are of comparable molecular weight, share a requirement for PLP as the cofactor and 
the product of one is the substrate for the other. Both enzymes bind adenosyl derivatives and the 
divergent transcription relation in facultative anaerobes led to the postulation that bioA was maybe 
the result of duplication and transposition of the bioF gene (57). 
1.2.3 Dethiobiotin Synthase (DTBS) 
The conversion of 7,8-diaminononanoate to dethiobiotin proceeds through three stages and is 
catalysed by a 47,600 Da homodimer. 
+ + 
Hf 	NH 3 











The conversion of 7,8-diaminonoflafloate to dethiobiotin 
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The protein dethiobiotin synthase (EC 6.3.3.3), encoded by the bioD gene, is a carboxylase (63). 
Distinct from others in its class, DTBS utilises CO 2  directly, and does not require biotin as a cofactor 
(64-65). DTBS also has a requirement for Mg 2t 
Originally discovered by Rolfe and Eisenberg (20) as a result of cross-feeding experiments, DTBS 
requires 1 mole each of its ATP and CO 2  substrates, producing I mole of ADP as release product 
(66). The active site stretches across the interface of the two monomers with the 7,8-
diaminononanoate substrate bound to one monomer, and the ATP substrate bound to the other (64). 
On binding, 7,8-diaminonononoate reacts with CO 2  to produce an 8-amino carbamate, the first 
intermediate (67). Although this reaction can proceed without catalysis, DTBS confers 
regiospecificity on the reaction, producing the N7 carbamate (68-70). Nucleophillic attack of this 
carbamate on the ATP substrate cleaves off an inorganic phosphate, resulting in the second 
intermediate - a phosphoric carbamate mixed anhydride (67). Closure of the imidazolone (ureido) 
ring through a tetrahedral intermediate forms the product dethiobiotin (DTB) (71-72), and in plants, 
a second intermediate 9-mercaptodethiobiotin, has been isolated (16) 
Although ATP is necessary as a substrate, the enzyme seems to lack the consensus ATP binding site 
GXGXXG (23) (73). It does, however, possess the P-loop sequence GTDTEVGKT 1 - one residue 
longer than that of the consensus (64) - a mononucleotide binding motif. 
DTBS has very little sequence similarity with any other proteins currently in the database, but the 
crystal structure of this enzyme, determined both by Alexeev et a! (64) and Lindqvuist et a! (74), 
display an overall resemblance of fold to adenylosuccinate synthase (PurA) and nitrogenase iron 
protein (NIP). All three are homodimers, but have little similarity in dimer organisation. 
Underlined residues are conserved 
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Figure 1.2.9 
The structure of DTBS (PDB: 1 BS1) was resolved to 1.65A (74)and 1.8A (Alexeev et a!, 1994) with 
space group C2. The active site is once again at the interface between the two subunits. 
The DTBS monomer is folded as a single cL/O globular domain (64) and the protein topology is 
similar to the oncoprotein Ha-ray-p2l. Other topological similarities are found between DTBS and 
other ATP dependent proteins. 
1.2.4 Biotin Synthase 
The bioB gene is located adjacent to the promoter palindrome sequence of the biotin operon in Ecu/i 
and encodes the 38kDa protein biotin synthase (EC 2.8.1.6), responsible for the insertion of a 
sulphur atom and subsequent closure of, the tetrahydrothiophene ring of the biotin molecule. This 
transformation involves the cleavage of two C-H bonds (75) of an inert methyl and methylene group 
(15) and ring closure proceeds via a thiol intermediate (76). 
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The conversion of dethiobiotin to biotin 
Investigation of the mechanism of this enzyme has led to the conclusion that several cofactors are 
also required for full catalysis: fructose- i ,6-biphosphate, S-AdoMet, Fe 2 , NADPH. KCI, cysteine 
cv.I 
(77-78) In plants, this enzyme has been, linked to a cellular organelle, possibly the mitochondri(i7) 
(79). The enzymes flavodoxin (PDB: 1AG9) and flavodoxin NADP reductase (PDB: 1FDR) are also 
necessary and participate in the electron cycling reactions (18). A third electron transport protein, 
MioC has also recently been discovered and is involved in FMN binding (80). The involvement of a 
low molecular weight product, thought to be derived from S-AdoMet and a breakdown product from 
the reaction catalysed by 7,8-diaminononaoate synthase, has also been suggested, but there is 
currently no firm evidence of the identity of this chemical (77) (L.A. Mclverpers. commun.). 
Biotin Synthase appears to act as a homodimer, with each monomer containing one [2Fe-2S] 2 
cluster with incomplete cysteinyl-S co-ordination. This cluster has been shown in the biotin synthase 
of E. coli (81) and B.sphaericus (82) to be reduced under anaerobic conditions to a [4Fe4S] 4 cluster 
with complete cysteinyl-S co-ordination, a process which is reversible under aerobic conditions. 
There are three other enzymes in the family of iron-sulphur cluster proteins. Anaerobic 
ribonucleotide reductase (83), lysine 2,3-aminomutase (84) and pyruvate formate lyase (85) also 
require S-AdoMet, Fe2  and the flavodoxin reduction system. Like biotin synthase, they catalyse 
reactions which involve proton abstraction from an activated carbon atom, achieved by free radical 
chemistry, using S-AdoMet as radical donor. This was investigated for biotin synthase in 1997 by 
Guianvarc'h and co-workers (86) and it was shown that a deoxyadenosyl radical was generated 
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together with methionine in equimolar amounts. Deuterium labelling studies suggest that one 
molecule of S-AdoMet is required for each C-H cleavage step. 
The sulphur, which is inserted into the tetrahydrothiophene ring has been shown to come from the 
iron-sulphur cluster of the protein itself (87). Thus regeneration of the cluster is necessary after each 
catalysis and it has recently been suggested that this is mediated by a NifS type protein (88-89) which 
mobilises sulphur from cysteine (and thiosulphate) for the formation of [2Fe-2S] 2 clusters (90). 
Cysteine itself has been shown to donate a sulphur atom (78), (91). 
All four enzymes of the iron-sulphur cluster family have a conserved cysteine triad CX 3CX2C. 
Mutation of these residues in E.coli biotin synthase to alanine (92) or serine (93) inactivated the 
enzyme. Some [2Fe-2S] 2  cluster formation was still apparent for the alanine mutations, but no 
evidence of this was seen on mutation of the residues to serine. 
1.2.5 Repression of Biotin Biosynthesis 
The production of biotin in E.coli is repressed as the result of negative feedback inhibition by the 
repressor protein product, BirA (EC 6.3.4.15), although it has been shown that repression of BioH in 
E.coli does not occur (94). The gene, birA, originally named bioR, was found together with the 
permeability protein encoded by NO at 85 min on the E.coli genome (14). BirA is a 33,500 Da 
monomeric protein and functions in conjunction with the allosteric effector biotinyl-5'-adenylate 
(bio-5'-AMP) (95), formed on reaction of free biotin with ATP and catalysed by BirA (96). It was 
recognised early on that the protein product of this gene had dual functionality (97-98). 
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Figure 1.2.11 
The structure of BIrA from Ecoli (PDB: 1BIA) was solved to 2.3A.(Wilson, 1992) with a space group 
P43212. cz-helices are shown in green, P sheets in blue. The putative DNA binding domain is bound 
loosely to the central domain. 
In the absence of maximal concentrations of biotin, the protein is constitutively expressed and BirA 
displays biotin-protein ligase activity in attaching the vitamin onto the BCCP subunit of a biotin-
requiring enzyme. In the presence of excess biotin in the cell (see section 1.2), BirA switches 
function and two monomers bind co-operatively to the two operator half sites of the biotin operon, 
thus repressing expression of the biotin at the genetic level (99-100). As levels of apo-BCCP rise 
once again in the cell, this enzyme competes with bioO for interaction with holo-BirA. In E.coli 
birA cells transformed with a multicopy plasmid containing the b1oABFCD operon produced biotin 
at levels 10.000 fold greater than wild type cells (34). 
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The enzyme consists of three domains. The N-terminal domain contains the helix-turn-helix DNA 
binding motif, suggesting operator repression occurs at the amino terminal. This is loosely associated 
with the central domain, one side of which is solvent exposed. Biotin binds at a site in this domain, 
and it is suggested that ATP binds to the protein at a nearby site. The C-terminal domain is 
composed of several anti-parallel 3 sheets and is not implicated in immediate substrate binding. 
Studies of the regulation of biotin in species of Bacillus conclude that inhibition is similar to that 
studied in E.coli and other bacteria (8) (30) (31) (101) but not in plants. Studies of Arabidopsis 
thaliana have revealed that the biotin ligase function of BirA is performed by biotin holo-carboxylase 
synthetase (HCS) (6). This enzyme is found in three locations in the cell, the cytosol, the 
mitochondria and the chloroplast, where it has an apparently high affinity for biotin (K m = 28nM) 
(102). The protein does not, however contain the helix-turn-helix DNA binding motif, and does not 
repress biotin production, a process that remains to be understood in plants. 
1.3 Pyridoxal -5'- Phosphate 
1.3.1 Mechanism of PLP catalysis 
The 5'-phosphate ester of pyridoxal (vitamin 13 6) is a versatile cofactor (103) in the enzymatic 
catalysis of reactions as diverse as: transamination; racemisation; a-decarboxylation; aldol cleavage 
and - and y-eliminations. Pyridoxal-5'-phosphate (PLP) effectively acts as an electron sink, in these 
reactions (104). Electrophilic reactivity is enhanced by the pyridine ring nitrogen of the coenzyme. 
This group reacts readily and reversibly with a lysine residue in the apoenzyme to form an imine 
linkage. The adjacent hydroxyl group (deprotonated at position 3 in figure 1.3.1) of the coenzyme 
enhances reactivity of the cofactor. As a free molecule, in the absence of an enzyme, PLP itself may 
undergo transaminations with amino acids (105). 
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Reaction of PLP with an amino acid. The incoming amino acid displaces the oxygen of PLP to form 
an imine bond. 
Characterisation of PLP dependent enzymes has shown that in the absence of substrate, the C 4 
aldehyde group of PLP is bound within the enzyme by a Schiff base linkage to the amino group of an 
active site lysine residue as an internal aldiniine. However, in the presence of a substrate, 
transimination occurs and an external aldimine is formed between the PLP cofactor and the 
substrate. There is evidence that the enzymes also change conformation from 'open' to 'closed' 
where access of the solvent to the coenzyme and bound substrate is prevented (60) (106). Both 
aldimines display planar geometry but the intermediate in these two steps, a geminal diamine, 
formed with both enzyme and substrate bound to the C 4 of PLP, displays tetrahedral geometry (107). 
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The proposed intermediates between the holoenzyme and the first quinonoid intermediate (104). The 
green arrows show progress of the reaction. Active site residues in the enzyme govern the stability 
and thermodynamic potential of the intermediates. 
Upon formation of the PLP external aldimine, the reaction proceeds via a resonance stabilised 
quinonoid intermediate (104) achieved by a-proton loss; decarboxylation, or side chain cleavage at 
the C atom of the substrate (fig 1.3.3). The type of reaction which precedes the initial quinonoid 
intemediate confers the specificity of the enzyme and is determined by the orientation of the bond to 
be cleaved, which must be perpendicular to the pyridine ring (108-109). It is this orientation which 
offers optimal overlap of the a and it electron orbitals of the substrate bond, thus labilising the it 
system of the ring most effectively (104). The quinonoid itself is stabilised relative to the external 
aldimine by the cofactor binding lysine and enhances reactivity within the active site. This is known 
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as the Circe effect (110). After cleavage at C, the mechanism can take one of several routes, 
resulting in radically different reactions. 
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Figure 1.3.3 
Versatility of PLP enzymes (107). The three possible routes of a PLP catalysed reaction all proceed 
through a quinonoid intermediate. 
1.3.2 Folding of PLP dependent enzymes 
Aminotransferases constitute the largest group in the a family of PLP dependent enzymes. 
Alexander and co-workers in 1994 (40) expanded the homology relationship of this superfamily 
during an investigation into the sequence homology of a large cross section of PLP dependent 
enzymes, defining four fold type subclasses by their differences in structural architecture. They 
defined three families of enzymes, a; 3 and y which correlated in the majority of cases with their 
mechanistic regio-specificity. The largest group of PLP dependent enzymes is represented by the a-
family which include the a-oxoamine synthase family (see section 1.2.1), all aminotransferases and 
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many amino acid decarboxylases. There are two amino acids, which are completely conserved 
throughout this family. The lysine which forms an mime linkage with the cofactor, and the aspartate 
residue which makes a salt bridge with the pyridine ring nitrogen (107). All aminotransferases were 
also found to contain a 7-stranded 0 sheet, a feature common to most PLP dependent enzymes in the 
cofactor binding domain (111-112), and sequence homology shows similarities in the hydrophobic 
and hydrophilic areas in this region. The structure of 8-amino-7-oxononanoate synthase has also 
been shown to contain the 7-stranded 0 sheet (see section 1.2.1), suggesting its presence elsewhere 
amongst members of the a family of PLP dependent enzymes. Grishin and co-workers reclassified 
the Alexander groupings in 1995 (56) after observing that members of the a- and 7-families 
displayed the same fold. They also restructured the subclasses of aminotransferases and assigned four 
principal fold types to describe the majority of PLP dependent enzymes for which secondary 
structures were available. A fifth was assigned to the fold type of glycogen phosphorylase, which uses 
the phosphate tail of PLP for catalysis, and two further folds, VI and VII, were tentatively introduced 
for enzymes of unknown structure. 
Fold type I is typified by aspartate aminotransferase (see section 1.3.2) and includes subgroups I, II 
and IV as defined by Mehta et a! (61) and members of the a and y families. Many of the residues 
interacting with the coenzyme are conserved. All monomer subunits are similar in size and contain a 
small amino terminal region, a large, central domain, and a smaller domain at the C-terminal. The 
large domain consists of several a helices packed around a 7-stranded 3 sheet. All strands except one 
run parallel to each other and the majority of cofactor binding residues arise from their carboxy-
termini. Other coenzyme - protein interactions are via residues from the opposite monomer. The 
small domain also has &f architecture. The core is a three or four stranded anitparallel 3 sheet. 
Differences between proteins are found between the N-terminal regions and in the position of the 
protein domains relative to each other. It is into this group that 8-amino-7-oxononanoate synthase 
has been classified. 
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Fold type H is best represented by the tryptophan synthase 13 subunit. It is a complex dimer of two 
fold 13/a pairs with the 13 subunits lying back-to-back. They each act independently, but are 
allosterically affected by one another. 
The structure of fold type III proteins differs from the general a13 fold of PLP dependent enzymes. A 
typical example of this fold type is alanine racemase, the structure of which is a TIM barrel ((13/a)8). 
The PLP cofactor is bound with the A face exposed to the solvent and initial mechanistic studies 
suggest that initial catalysation is achieved by a two base mechanism involving tyrosine as well as 
the critical cofactor binding lysine residue (113). 
D-amino acid aminotransferase is a good example of fold type IV. This enzyme is a member of the 
aminotransferase subgroup III and the active site serves to orientate the cofactor so that the A face of 
PLP is solvent exposed. This is in direct contrast to the B face exposed in enzymes of fold types I and 
II, but similar to fold type IH. 
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Aims of this Project 
The AONS protein from E.coli has been structurally and biochemically characterised (36-37). It is 
present in solution as a homodimer of 83 kDa and catalyses the decarboxylative condensation of L-
alanine and pimeloyl-CoA to form 8-amino-7-oxonOnanOate synthase. 
Studies of the active site have revealed certain crucial residues. Lysine 236 forms a Schiff base 
linkage to the C4' of the PLP cofactor and is also believed to be the general base for proton 
abstraction prior to the formation of the first quinonoid intermediate in the reaction pathway. 
Histidine 133 lies in parallel with the pyridine ring of the cofactor and participates in the 71 electron 
system to stabilise the PLP molecule within the active site. In order to discover the exact nature of 
activity of these residues, point mutations have been made, and the mutated proteins purified and 
characterised using a number of biophysical techniques. 
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Materials and Methods 
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Equipment used has been cited where appropriate. Reagents were purchased from Sigma, Gibco 
BRL, Fisher Scientific, Phannacia, Difco, Acros and were of suitable grade for research purposes. 
2.1 Microbiology 
2. 1.1 Cell Lines and Plasmid Vectors 
All cell lines were derived from Escherichia co/i and stored at -20°C or -80°C in 10% glycerol until 
required. Commercially competent cells were purchased in batches and stored in 1OjtI or 25p1 
aliquots at -80°C. 
Table 2.1 
Eschenchia coil strains used throughout the project 
Cell Line 	 Genotype 	 Description of use 
Escherichia co/i JM1O1 (114) 
Escherichia co/i JM 109 (114) 
Top 10 One Shot competent 
cells (Invitrogen) (115) 
Escherichia coli HMS 174 (DE3 
lysogen) (Novagen) (116) 
F'; traD36; /acI;  A (lacZ); MIS; 
proAB/supE thi; A (lac-proAB) 
F'; traD36; /acI;  A (/acZ); MIS; 
proA'B/e14- (mcrA-); A (lac-
proAB); thi gyrA96 (NaP); endA 1; 
hsdR17 ( rkmk); re/Al; supE44; 
recA 1 
P; mcrA; A(mrr-hsdRMS-mcrBC) 
801acZAM15; A/acX74; deoR; 
recA 1; araD 139; A(ara-/eu)7697; 
galU; ga/K; ipsL; endA 1; nupCI 
F; recAl; hsdR(rkI mk124); Rif 
(DE3) 
Storage of DNA as glycerol 
stocks at -80°C 
A recK cell line to obtain 
stocks of plasmid DNA from 
overnight cultures. 
recK cell line from E.coli to 
obtain stocks of plasmid DNA 
from overnight cultures. They 
replaced the JM109 strain. 
Constructed with a DE3 
lysogenic region, which acts 
upon the /ac promoter present 
in pET plasmids, this strain 
was used for expression of 
protein. 
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High copy number plasmid vectors were used to obtain and amplify DNA. Low copy number 
plasmids were used for protein over-expression, where they were placed under the control of a 
bacterial host repressor. 
Table 2.2 
Bacterial vectors. pDC13 was constructed by Dr. Dominic Campopiano (University of Edinburgh) and 
consists of the insertion of a ribosome binding site into a pUCI8 vector. Use of this plasmid was by 
kind permission. 
Plasmid Phenotype Copy Number Description of use 
pUC18 (Novagen) ampr;  lacZ' 500 This vector was used to 
obtain DNA stocks, as the 
COPY 	number 	is 
uncontrolled 
pDCl3* (pUCI8IRBS) amp'; lacZ' 500 Designed 	for 	protein 
expression, 	this 	plasmid 
was 	used 	for 	mutated 
proteins. 
pET 16b (Novagen) amp'; T7 promotor; Xa - 50 Derived 	from 	pBR322 
protease cleavage site and 	171ac 	promotor 
control 	of 	gene 
expression. 	Use 	in 
HMS174 (DE3) cell line 
for protein expression 
pET6H amp'; 17 promotor; Xa - 50 Derived 	from 	pBR322 
(pET lid derivative protease cleavage site; and 	171ac 	promotor 
created at Edinburgh) N-terminal 6 Histidine control 	of 	gene 
sequence expression. 	Use 	in 
HMSI74 (DE3) cell line 
for protein expression 
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All microbiology work was carried out using asceptic techniques. Broths and containers were all 
autoclaved (121°C for 20 min at 15 psi). Sterile 20m1 universal tubes (Invitrogen) were utilised for 
small overnight cultures and larger bacterial cultures were grown up in 500m1 shake flasks (Sigma) 
or a glass 10 litre fermentor (New Brunswick Scientific). All cultures were cultivated in 2YT (16g/l 
Bactotryptone, I Og/l Yeast Extract, 5g/l NaCl, pH 7.5) or Luria Bertani (I OgIl Bactotryptone, 1 Og/l 
NaCl, 5W1  Yeast Extract, pH 7.5) broth by agitation (250rpm) at 37°C. Commercial competent cells 
were initially grown and plated out in SOC (20gIl Bactotryptone, 5g11 yeast extract, 0.5g11 NaCl, 5g/l 
MgSO4, 3.2g/1 glucose, pH 7.5) media. Unless otherwise stated, transformant cells containing vectors 
pUC 18, pET 1 6b and pET6H were spread onto agar plates (1 5g11 bacto-agar in LB broth) containing 
100tgIml ampicillin and also grown in the presence of 100ig/ml ampicillin. 
Aliquots of 1 ml of each transformant were frozen with 10% glycerol at -20°C over 48 hours and then 
transferred to -80°C for storage. These represented the glycerol stocks used for storage of all clones. 
2.1.2 Preparation of Competent Cells 
A 20.tl aliquot of the desired strain of E. coli was used to innoculate lOmI LB (Luria Bertani) broth 
The culture was grown up overnight. A 200tI aliquot of this overnight culture was then transferred 
into 9.8m1 LB broth solution containing 20mM MgCl 2 and grown for a further 50 minutes until 
= 0.2 (Unicam UV/vis spectrophotometer UV4). The cells were harvested (Denley BR40 1 
3,000 rpm, 15mm, 4°C) and the supernatant discarded. 
The pellet was re-suspended in 4m1 transformation buffer (10mM Tris, pH 8.0, 50mM CaCl 2) and 
stored on ice for 30 minutes before further centrifugation of the cells (Denley BR40I 3,000 rpm, 
15min, 4°C). The supernatant was discarded and the pellet re-suspended in 400tI transformation 
buffer and stored on ice for 12-24 hours (117). 
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This process was employed for the first 12 months of research. During this period, transformation 
efficiency became increasingly lo7er, resulting in the subsequent purchase and employment of 
competent cells from a commercial origin for the remaining period of research. The initial pellet was 
stored on ice for 2 hours in 4 ml transformation buffer to increase final transformation efficiency 
and, after the final incubation period, frozen in 1001.tl aliquots at -80°C. 
2.1.3 Transformation 
Non-commercial origin: 
1-15tl of the desired DNA (up to bOng) was added to lOOj.tI competent cells, gently mixed and 
placed on ice for 30 -minutes. The cells were subjected to a heat shock (37°C, 5 mm) and lml 
warmed (37°C) 2YT broth was added. The cells were left for 1 hour at 37°. Cells were then pelleted 
(MSE microfuge 13,000rpm, 5 mm, RT) and the supernatant discarded. The pellet was re-suspended 
in 50tl 2YT broth and spread to dryness on 2YT/amp (100tg/ml) agar plates. The plate was 
incubated overnight at 37°C. 
Commercial Top 10 One ShotTm cells: 
1-5.tl (up to 40ng) DNA was added to 25tl Top 10 One ShotTm cells, gently mixed and stored on ice 
for 30 minutes. The solution was then heated (42°C) for exactly 30 seconds and returned to ice for a 
further 2 minutes. 2001tl SOC medium was added and the cells agitated (250rpm, 37°C) for one hour 
before a 40tl aliquot was plated to dryness on a 2YT/amp agar plate. This was incubated overnight 
at 37°C. 
Commercial HMS174 (DE3) cells: 
1-5p.tl DNA (up to 40ng) was added to 10t1 competent HMS 174 (DE3) cells, gently mixed and 
stored on ice for 30 minutes. The solution was then heated (42°C) for exactly 30 seconds and 
returned to ice for a Farther 2 minutes. 80tl SOC medium was added and a 40lil aliquot plated to 
dryness on a 2YT/amp agar plate which was incubated overnight at 37°C. 
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1, Unicam UV.vis spec. UV4), the cells were induced with IPTG to a final concentration of 1mM and 
allowed to grow for a further period of three hours. 
The cells were harvested (Sorvall SLA 1500 rotor 7,000 rpm, 10 mm, 4°C) and the final pellet 
washed with 20mM potassium phosphate buffer (20mM K 2HPO4, 20mM KH2PO4, pH 7.5; 2mM 
EDTA). 
At this point, the pellet could be frozen at -20°C and the purification process continued at a later date 
if necessary. A frozen cell pellet was thawed on ice before re-suspending it in buffer for further 
purification. 
The washed pellet was re-suspended in 20mM potassium phosphate buffer (4ml buffer/i g pellet) and 
the cells disrupted by sonication (MSE Soniprep 15 x 30 sec bursts at 14 amplitude microns). The 
resulting cell suspension was centrifuged (Sorvall SS-34 rotor 10,000 rpm, 30 mm, 4°C) and the 
pellet containing the cell debris discarded. If the cell pellet was tinged with yellow, it was re-
sonicated to extract any remaining protein. 
The supernatant represented the cell free extract to be consecutively fractionated with ammonium 
sulphate; heated; or loaded straight onto an affinity column. 
2.2.3 Ammonium Sulphate Fractionation 
Due to the heat sensitive nature of E. co/i AONS proteins, the following steps were carried out on ice 
or at 4°C. 
For wild type and mutant AONS proteins from E. co/i, the crude extract was initially cut by slow 
addition of 35% ammonium sulphate (19.7g (NH4)2SO4 /iOOml protein solution) with gentle 
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agitation and subsequent centrifugation (Sorvall SS-34 rotor 10,000 rpm, 30 mm, 4°C). The white 
pellet was discarded. 
E. coil AONS was then precipitated by increasing the ammonium sulphate content of the supernatant 
to 65% (18.7g (N111)2SO4 /lOOml protein solution). After slow addition of ammonium sulphate, the 
solution was left to stir gently overnight at 4°C. 
The precipitant mixture was subsequently centrifuged (Sorvall SS-34 rotor 10,000rpm, 30 mm, 4°C) 
and the supernatant discarded. The pellet was re-suspended in an arbitrary amount of 20mM 
potassium phosphate buffer (supplemented with 20% (10.7g (NH 4)2SO4 /lOOml buffer) and syringe 
filtered (0.45 J.=) in preparation for chromatographic purification. 
2.2.4 Consecutive heat treatment 
After obtaining the crude extract, initial purification of AONS from Aqufex aeolicus was 
commenced by heating. In order to avoid rapid precipitation of cellular proteins, which may have 
resulted in the removal of AONS from the solution, the crude extract was heated first at 60°C for 10 
minutes. The solution was centrifuged (Sorvall SS-34 rotor 10,000rpm, 30 mm, 4°C), the pellet 
discarded, and the supernatant heated to 80°C for a further 10 minutes. After centrifugation as 
above, the pellet was discarded and the supernatant filtered (0.45tm) in preparation for 
chromatographic purification. 
2.2.5 Hydrophobic Interaction Chromatography 
A HiLoad 16/10 Phenyl Sepharose column (Pharmacia Biotech) - column volume 25m1 - was 
calibrated with 20mM phosphate buffer containing 20% ammonium sulphate. The protein extract 
was run on a linear ammonium sulphate gradient decreasing over 10 (or 20) column volumes from 
20-0%. This technique was used for the initial chromatographic purification of E.coli AONS. 
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2.3.2 DNA Isolation from Agarose 
DNA fragments were excised from the agarose gel with a sharp blade and transferred into an 
Eppendorf tube. They were then purified using the Prep-a-Gene® kit (Bio Rad) or QlAquick 
(QIAGEN). DNA was eluted in a volume of 40j.tl. 
2.3.3 DNA Restriction Digests 
A volume of I il restriction endonuclease was used for each digest. This was added to the DNA 
solution along with an appropriate buffer. Incubation of the digests was at 37°C. 
For analysis purposes, one hour digests of 5-10tl bioF DNA with the appropriate enzymes and 
corresponding buffers were run on 1% agarose gel. 
For ligation purposes, 10-20il plasmid DNA was restricted overnight Each digest was run on a 1% 
agarose gel to verify size and then retrieved from the gel as described above (see section 2.3.2). 
2.3.4 Ligation of DNA 
Digested DNA (section 2.3.3) retrieved from agarose gel by the Prep-a-Gene® kit was ligated 
together at room temperature over 48 hours. A typical ligation involved: I3tl bioF DNA; 3pi 
plasmid DNA; 2tl T4 ligase (New England Biolabs); 2tl T4 ligase buffer (New England Biolabs). A 
control reaction was run alongside the ligation, replacing the 13tl insert DNA by H 20. 
Complete ligations were then transformed into ToplO One ShotTm competent cells and the new 
construct retrieved from overnight cultures by the Wizard Mini-Prep® (Promega) or QiAprep 
(QIAGEN). 
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2.2.6 Anion Exchange Chromatography 
For the final stage of purification, wild type and mutant AONS from E.coli, were loaded onto a 
HiLoad 16/10 Q-sepharose 50m1 column (Pharmacia Biotech). Protein from desirable fractions 
collected after hydrophobic interaction chromatography was pooled and dialysed against 20mM 
potassium phosphate buffer to remove excess (NH) 2SO4  and syringe filtered (0.45Rm). The protein 
was eluted over 20 column volumes using a linear NaCl (0-IM) gradient. This method was also 
employed for the separation of A.aeolicus AONS. 
Fractions showing protein impurities were further purified using a Resource Q lml column 
(Pharmacia Biotech) run as above. 
2.2.7 Nickel Affinity Chromatography 
This column was used for the preparation of 1-Iis 6-tagged AONS from E.coli. 
A HiTrap® 5m1 chelating column (Pharmacia-Biotech) was first charged with 50mM NiSO 4 to 
produce the nickel chelation resin of the column. 
The filtered crude extract was !oded onto the column in binding buffer (5mM Imidazole; 0.5M 
NaCl; 20mM Tris-HCI, pH 7.9). The column was washed with 5 çIumn volumes of wash buffer 
(60mM lmidqzole; 0.5M NaCI; 2QM Tris- - CI, pt-I 7.) an4 protein eluted with 5 column volumes 
of elution buffer (1M Imidazole; 0.5M NaCI; 20mM Tris-Ucl, pH 7.9. 5m1 fractions were collected 
in 20rnl 20mM potassium phosphe buffer, .pH 7.5 or an initial dilution pf imidazole. Protein 
fractions were pooled and çlysed. eausjvely agnst 20mM  pçgssium phosphate tç reoe 
the imidazoje. 
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2.2.8 SDS Polyacrylamide Gel Electrophoresis (SDS PAGE) 
The contents of chromatographic fractions were analysed by SDS PAGE (118). 
SDS sample buffer (100mM tris.HCI, pH 6.8, 20% (w/v) glycerol, 15% (v/v) 3-mercaptoethanol, 3% 
(w/v) SDS, 0.25% (wlv) bromophenol blue) was added to each protein fraction (v/v) and then boiled 
for five minutes. A 15tl volume of each sample was loaded onto a 4% stacking gel and run through 
a 15% separating gel at 200V for approximately 45 minutes (Bio Rad Protean II discontinuous buffer 
minigel system), in SDS running buffer (180mM Glycine, 25mM Tris, 0.1% w/v SDS). 
The size of proteins was gauged using a low molecular weight standard (Pharmacia, 14.4 - 94 kDa). 
Gels were stained with Coomassie Blue R250 (40% Methanol, 10% Acetic acid, 0.1%w/v Coomassie 
Blue - R250), de-stained (40% Methanol, 10% Acetic acid) and visualised under white light. 
Completed gels were incubated overnight at 37°C in a water bath containing 1% glycerol and dried 
using Gel Drying Film (Promega). 
2.2.9 Determination of protein concentration 
An approximate estimate of the concentration of a protein solution was used to gauge the amount of 
protein to be loaded onto a purification column and was obtained by measuring the optical density of 
the sample (Unicam UV/vis spectrophotometer IJV4). An 0D 280,,,,, value of 1 is approximately equal 
to 1mg/mi protein concentration (119). 
Accurate concentrations were measured using the Bradford Assay (120) or the BCA Protein Assay 
Reagent (Pierce) as per manufacturer's instructions. In both cases, Bovine Serum Albumin was used 
as a reference. 
Pure protein was frozen at -20°C with 10% glycerol (v/v). 
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2.2.10 Protein Mass Spectrometiy 
Protein samples (0.5p.M) were separated from the salt in the buffer on a 5xg C-4 300A column 
(Jupiter) at constant 0.01% acetonitrile concentration and a 10-100% linear gradient acetonitrile in 
water (Waters 2690 1-IPLC unit) over 40min at a flow rate of 0.05m1/min. Separation was monitored 
at 280nm (Waters 486 Tunable Absorbance Detector) and on removal of the salt, the HPLC was 
connected to a Platform H quadrupole mass spectrometer (Micromass) equipped with an negative 
electrospray ion source. The cone voltage was set to 70V and the source temperature to 65°C. 
Scanning at intervals of 0.1 see, the scans were accumulated, the spectra combined and the average 
molecular mass determined using the MaxEnt and Transform algorithms of MassLynx software 
Version 2.3 (Micromass). 
2.3 Molecular Biology 
2.3.1 Agarose Gel Electrophoresis 
DNA samples were mixed with 6x loading dye (blue/orange, Promega) and run on a 1% agarose (Gibco BRL) 
gel containing 5j.tl (lOmgIml) Ethidium Bromide for analysis. The samples were run (Gibco BRL H5 system) 
in TAE buffer (40mM Tris-acetate, 1mM EDTA) for approximately 45 minutes at 100V. DNA fragments 
were visualised under ultraviolet light. 
Fragment size was gauged using ?.FlindHI standard (23kb-0.5kb) and/or PCR standard (I Kb - SObp) (Sigma). 
Subsequently, these standards were replaced by Hyperladder I (1 OObp - 10Kb) and Hyperladder IV (50bp - 
1Kb) (Promega). 
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2.3.5 DNA Mutagenesis 
Site directed mutagenesis was conducted by the Polymerase Chain Reaction megaprimer method 
(121) to specifically mutate certain DNA bases corresponding to amino acids present within the 
active site of AONS. All primer oligonucleotides for mutagenesis were used at a concentration of 
I OtM. The underlined codons represent the mutated residues. Restriction sites are highlighted in 
bold. 
EcoRl 	BspHI 
FEcoBsp primer 	5'- CGC GAA TFC GTC ATG AGC TGG CAG GAA AAA -3' 
M13 reverse pUCI8 primer 	 5'- CGC CAG GGT TTT CCC AGT CAC -3' 
K236A forward mutant primer 	 5'- ACT ITT GGC GCA GGA ITT GGC -3' 
H133F forward mutant primer 	 5'- CGG CTT AGE TTC GCC TCA TTG -3' 
NcoI 
AQF Forward primer 5'-CAT ACT GGG AAT TCC ATG GGT TGG AlT GAG GAG GAA-3' 
AQF Reverse primer 	 5'-GGC GGA TCC TAA GCC CIT CCT 1T-3' 
AQF HI 18F forward mutant primer 	5'-GAC GAA TTA AAT TTC GCA TCT ATA ATA-3' 
FEcoBsp and M13 primers were used as the forward and reverse primers respectively for mutations 
within E.coli bioF and the AQF forward and reverse primers for A.aeolicus bioF. 
2.3.5.1 Production of Megaprimers 
The following were combined in a 0.5m1 PCR tube: 1.tI template DNA (pUCI8/bioF); 1O.tl 5x PCR 
buffer (335mM Tris, pH 8.8, 83mM (NH4)2SO4 , 33.5mM MgCl 2 , 50mM 2-Mercaptoethanol, 33.5p.M 
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EDTA, 0.82mg/mi Bovine Serum Albumin, 7.5mM dNTPs); 5p.l M13 primer (l0tM); 5.ti mutant 
primer (10j.tM); 28pi H20; lj.tl Deep Vent Polymerase (New England Biolabs) and gently mixed. 
The solution was covered with a layer of liquid paraffin and placed in the Perkin Elmer 480 Thermal 
Cycler. PCR was conducted over 30 cycles (95°C, 1 mm; 54°C, 1 mm; 72°C, 2mm). A final 5 
minute extension at 72°C encouraged final coupling of DNA bases and the reaction was analysed by 
1% agarose gel electrophoresis. 
2.3.5.2 Mutant Extension 
Megaprimers were isolated from the agarose gel and used as the reverse primer for the mutant 
extension reaction. The M13 reverse primer was replaced by the FEcoBsp primer. The following 
were combined in a 0.5ml PCR tube: 1.tI template DNA (pUC18/bioF); lOp.tl mutant megaprimer; 
5.tl FEcoBsp primer (lOp.M); 34tl H 20; 2 Ready-to-go® PCR beads (Pharmacia Biotech) and cycled 
as above. 
2.3.5.3 Mutant Amplification 
Mutant extensions were isolated from the agarose gel and used as the template for the final 
amplification reaction. The forward and reverse primers were FEcoBsp and M13 respectively. 
Components were combined in a 0.5m1 PCR tube and cycled as above. 
Amplified EcoRIJBamHI restricted mutants were ligated into a EcoRlJBamFll restricted pUC18 
vector respectively and verified by agarose gel electrophoresis and dRhodamine sequencing. Correct 
constructs were then digested EcoRlJBamHl, and subsequently Bsp}llIBamFll and ligated into 
NcolJBamHl restricted pET 16b vectors. 
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2.3.6 DNA sequencing 
Mutants ligated into pUC 18 vectors were sequenced to ensure that the construct was correct. An 8.tI 
volume of sequencing premix (PE Applied Biosystems) was combined in an 0.5m1 PCR tube with 
10.tl mutant DNA, ljtl M13 reverse primer and 1.tl H 20 for the reverse reaction, replacing the M13 
primer with lj.tl NR (NEW REV) pUCI8 forward primer (5'-GTT GTG TGG AAT TGT GAG 
CGG-3') (Gibco BRL) for the forward reaction. A layer of paraffin oil was added and the reactions 
thermally cycled (96°C, 30 sec; 45°C, 15 sec; 60°C, 4 mm) for 30 cycles. 
The oil was removed, the PCR reaction transferred to an Eppendorf tube and 7p.l ammonium acetate 
(1/3 vol) added. 2.5 volumes of 95% ethanol was then introduced and the entire mix stored at -20°C 
for 2 hours. 
The solutions were centrifuged (MSE microfuge, 13,000rpm, 15 minutes, RI) and the supernatant 
discarded. The pellet was repeatedly washed with 500tl 70% ethanol and centrifuged as above. The 
pellet was dried under a vacuum for 10 minutes (Gyrovap). Sequencing was carried out by Sanger 
dideoxy chain termination (122) on an ABI Prism 377 DNA sequencer. Results were analysed using 
ABI Prism editview software for the Apple Macintosh, and subsequently Vector NO software 
(InforMax Inc.) 
2.4 Enzymology 
2.4.1 Steady State Kinetics 
Frozen aliquots of AONS protein solution were thawed on ice and dialysed in 20mM potassium 
phosphate buffer containing 100.tM PLP (pyridoxal-5'-phosphate, Sigma) for one hour. 
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Enzymatic activity of AONS and consequent production of Coenzyme A was coupled to CoA 
consumption of a second enzyme ct-ketoglutarate dehydrogenase (36) (47). All assays were carried 
out at 30°C unless otherwise specified in the text. 
A typical assay contained: 20mM potassium phosphate buffer, pH 7.5; 10 x assay buffer 2 ; varying L-
alanine; varying Pimeloyl CoA; 0.01 U a-ketoglutarate dehydrodgenase (Sigma); I tM AONS made 
up to a final volume of lml with H20 
The reference cell contained all components with the exception of AONS. The progress of the assay 
was recorded on a Hewlett Packard 8452A Diode Array Spectrophotometer at a wavelength of 
340nm using Multicell Kinetics software. The assay proceeded for 10 minutes and was monitored at 
10 second intervals. The data were fitted to Michaelis-Menton saturation curves according to 
equation 1. 
Vmax[S] Vo= . ....................................................Equation I 
[S] + K 
This assay was developed by Dr Scott Webster from an assay for ALAS (47). Pimeloyl CoA is not 
commercially available, thus it was synthesised in the laboratory according to (38), using 7-
(phenylthiocarbonyl) heptanoic acid and Coenzyme A (Sigma) as starting materials. 
2.4.2 UV Spectral Analysis 
Frozen aliquots of AONS protein solution were thawed on ice and dialysed in 20mM potassium 
phosphate buffer containing l00j.tM pyridoxal-5'-phosphate (Sigma) for one hour. Non-enzyme 
bound PLP was removed by multiple washes with 20mM potassium phosphate buffer through a 
Centrex UF2 concentrator (Schleicher & Schuell). Complete removal of free PLP was monitored by a 
decrease in absorbance at 390nm and subsequent shift to 41 Onm-430nm (Hewlett Packard 8452A 
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Diode Array Spectrophotometer). The protein in its washed state was used initially to calculate the 
absorbance coefficient of the enzyme-cofactor complex chromophore. 
2.4.2.1 pH stability 
The prepared enzyme (8-1OtM) was incubated with 1M HEPES buffer, adjusted to a pH value in the 
range pH 6 - pH 9, for 20 minutes at 30°C. For AONS protein from A.aeolicus, this incubation was 
also conducted at 60°C. The resulting spectra were measured against a reference of 1M HEPES 
buffer at the relevant pH (Hewlett Packard 8452A Diode Array Spectrophotometer) using General 
Scanning (DOS based) software. 
2.4.2.2 Temperature stability 
The prepared enzyme (10.tM) was heated at various temperatures between 0-100°C for 10 minutes. 
A 50i.tI aliquot of the heated protein solution was then assayed (see section 2.5. 1) at 30°C. 
An additional experiment for the stability of AONS from 4aeoliczs was to qscpluiti the activity 
profile in relation to temperature. A 5041 aliquot of dialysed enzyme (I Oi.tM)  was ipcubated with 
10mM potassium phosphate buffer; 55mM L-alanine and 1501.tM Piineloyl CoA for 10 minutes at 
specific temperatures between 0-100°C. Reactions were then quenched with tricarboxylic acid 
(Sigma) to a final concentration of 1% and centrifuged to pellet the denatured protein (MSE 
microfuge 13,000rpm, 5 min, RT). A 50.tl volume of the supernatant was then assayed with 20mM 
potassium phosphate buffer, 1 Ox assay buffer, 0.01 U a-ketoglutarate dehydrogenase, made up to 1 ml 
with 1120 at 30°C. 
2 1 O assay buflr contains: 10mM NAD; 30mM M5Cl2; 2.5mM thiamine pyrophosphate; 10mM a-ketoglutarate 
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initial screens using Structure Screen I and II (Molecular Dimensions Ltd) and an ammonium 
sulphate screen. A 100tl volume of screening solution was introduced into the plate well. Protein 
solution and well solution (vlv) were combined in a droplet, which was placed on the platform. Wells 
were covered with polythene tape and incubated at the desired temperature. 
2.5.3 X-ray diffraction 
Crystals varying in size from I OO-600nm were mounted in Cryoloops (Hampton Research) and 
frozen in liquid nitrogen, using Paraton N oil as the cryoprotectant. X-ray diffraction was carried out 
at lOOK at SRS, CLRC Daresbury Laboratory on Station 7.2 using a MarResearch 345mm image 
plate and wavelength X=1.488A. 
The data was processed using DENZO (123) and scaled with the SCALEPACK software (124). 
2.5.4 Crystal structure solution 
Diffraction data parameters were obtained using the Computational Crystallography Project 4 
(CCP4) suite of programs software (125), (www.dl.ac.uk/CCP/CCP4/main.html).  
Phasing was solved by molecular replacement(126), using the structures of both E.coli (37) and 
Bacillus sphaericus (Cambillau & Ploux, 2000, unpublished) AONS as search models. An electron 
density map was created using CCP4 software and the structure was refined manually in 0 (127), 
(http://xray.bmc.uu.se ) and computationally in CNS XPLOR (128). 
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2.5.5 Polymer formation 
A Superose 200 column (Amersham Pharmacia) of volume 360m1 was equilibrated with 20mM 
potassium phosphate buffer, pH 7.5 and 100mM NaCl and calibrated with imi protein solution 
containing 1mg each of Bovine serum albumin (66kDa); Ovalbumin (45kDa); Carbonic anhydrase 
(29kDa); Cytochrome C (12.5kDa) and blue dextran (1,000kDa). Blue dextran eluted at 1 lOml, 
which was termed the void volume. Elution volumes of the standard proteins were then calculated by 
subtraction of the void volume from the elution volume. The ration of elution volume to void volume 
was plotted against the logarithm 10  of the molecular weight of each standard to obtain a standard 
curve. One millilitre protein solution containing 2mg A.aeolicus AONS and 1mg blue dextran was 
then loaded onto the column and allowed to elute. The molecular weight of AONS in its native form 
was read from the standard curve. 
2.6 Bioinformatics 
All programs were accessed either on their original server, or through the database service provided 
by the Human Genome Mapping Project (www.hgmp.mrc.ac.uk ). 
2.6.1 DNA Sequence Retrieval 
DNA sequences were retrieved from the European Molecular Biology Laborotory (EMBL) database, 
held at the European Bioinformatics Institute (EBI) (www.ebi.ac.uk ) or from the Genome 
Representative Organisation sector of Genbank (www.ncbi.nlm.nih.govfEntreziGenOmelOrg.html). 
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Protein sequences were retrieved using the SWISSPROT and TrEMBL databases accessed through 
the Swiss ExPASY3  server (www.expasy.chl) of the Swiss Institute of Bioinformatics. Alternatively, 
sequences were directly retrieved from the Sequence Retrieval System (www.srs.ac.uk ) supported by 
EBI 
2.6.2 Protein Sequence Alignment 
Protein sequences were accessed (see above section) and converted into PIR format. This data was 
pasted into the EMBL based alignment engine CLUSTALW that is found on the sites of the EBI and 
several mirror sites and alignment carried out with the default scoring matrix algorithm (BLOSUM 
62). The resulting alignment was adjusted in Align X (InforMax Inc.). Secondary structure 
alignment was computed via the DSSP program. Several protein sequences were aligned and an 
evolutionary dendrogram created using Vector NO software. 
2.6.3 Protein Structure Retrieval 
Released protein structures were accessed from the Brookhaven Protein Databank (PDB) 
(www.rcsb.org) using a four digit identification code. The downloaded data was manipulated in 
Swiss-313, a shareware program offered by the Swiss Institute of Bioinformatics. 
Expert Protein Analysis System 
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3.1 Isolation and Purification of wild type and His6-tagged AONS 
3. 1.1 Purification of wild type AONS 
The bioF gene was initially cloned from p13030 15/9, a plasmid containing the whole E.coli hio operon 
fragment, into pUC 18 as an EcoRl/BamHI fragment. Bspl-ll/BamHI fragment containing the gene was 
subsequently sub-cloned into the NcoI/BamHl site of the over-expression vector pET I 6b, destroying both 
the BspHI and Ncol site (36). 
1111(291) 
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Figure 3.1.1 
The vector pET16b containing the bioF gene from E.coii. The gene was sub-cloned as a BspHI/BamHl 
fragment into a Ncol/BamHl digest of pET16b where it was placed under the control of a powerful 17 
inducible promotor. 
AONS was over-expressed in HMS 174 (DE3) cells which were induced with a final concentration of 
1mM IPTG for three hours before harvesting. The protein was purified by sequential ammonium 
sulphate fractionation and hydrophobic interaction chromatography followed by anion exchange 
chromatography (see section 2.2). 
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The approximate yield was 10mg/litre of protein of 95% purity as estimated by SDS PAGE. Initially, the 
protein displayed the characteristic yellow colour of its PLP cofactor, but the majority of this colour 
disappeared on purification, dialysis or freezing. Details of activity at each purification step are shown in 
table 3.1 
Table 3.1 
Purification table of Ecoli AONS from expression of HMS 174 (DE3). Protein concentration was 
measured using the method of Bradford (120) and specific activity was measured in a coupled assay 
using 50mM L-alanine and 200PM pimeloyl-00A. 1U AONS represents the transformation of 1j.imol 
pimeloyl-00A per minute at 30°C 
Purification Step Volume Protein Specific Total 
Yield Purification 
(ml) (mg/ml) activity activity (%) fold 
(LI/mg) (U) 
Crude extract 50 55 -- -- -- -- 
65% ammonium sulphate 45 50 0.02 45 
100 
Hydrophobic interaction 104 1.8 0.2 
37.4 83 10 
Anion exchange 44 2.1 0.4 37 
82 20 
3.12 Purification of His 6-tagged AONS 
The addition of an N-terminal tag consisting of 6 histidines was designed to allow for a faster 
purification of both wild type and mutant AONS proteins. The bioF gene was sub-cloned from pUC 18 by 
excision of the EcoRI/BamHl fragment and subsequent digestion to obtain the BspHl/BamHl fragment. 
This was directionally ligated into the tagged over-expression vector pET6H at the NcoI/BamHI regions 
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of the polycloning site, eliminating both the BspHl site and the Ncol site, as before. The T7 inducible 
promotor of the vector was located upstream of the 6-histidine sequence (MHHHHHHA), so induction 
with IPTG resulted in production of the tagged protein. 
The resulting cell free extract was loaded directly onto a nickel affinity chromatography column and 
His6-tagged AONS eluted at the second column volume of elution buffer. 
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The pET6H vector containing the bioF gene. Transcription of the gene results in a protein with a N-
terminal 6 histidine tag. Expression is controlled by the 17 IPTG-inducible promotor. 
Protein fractions were collected in tubes containing 20mM potassium phosphate buffer, pH 7.5 in a 
fraction : buffer ratio of 1:3. The elution buffer contained an elevated concentration (1M) of imidazole, 
and collection of the fractions in this manner prevented precipitation of the eluted protein. Exhaustive 
dialysis of the protein removed the imidazole and 6His-tagged AONS was frozen at -20°C. A typical 
preparation yielded 15mg/I His 6-tagged AONS of 95% purity as estimated by SDS PAGE. Specific 
activity of the purified protein was 0.4U. 
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3.2 Physical characterisation of His6-tagged AONS 
3.2.1 Cofactor Binding 
The absorption coefficient () of the enzyme-cofactor imine linkage was measured as 7,752 1 mol' cm', 
a value corresponding to that of the unmodified wild type (see section 5.2.1). Thus there was no 
significant difference in measured affinity of the His 6-tagged protein for its cofactor and loss of colour on 
freezing and dialysis of the unmodified enzyme. 
3.2.2 Mass spectrometry 
ES! mass spectrometry was performed on FIis 6-tagged AONS and the spectrum can be seen in fig 3.3.1. 
The measured molecular weight value of the apo-enzyme indicates a mass corresponding to the post-
translational cleavage of the formyl methionine residue from the tag. This is the same as the post-
translational modification procedure observed on the unmodified wild type enzyme (36). The measure 
mass of 42,627 Da was 8 Daltons greater than the predicted value of 42,619 Da, an error of 0.02%. 
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3.3 Absorbance spectra of wild type and His6-tagged AONS 
3.3.1 Absorbance spectra of wild type AONS 
Monitoring of the UV/visible spectra of both enzymes with their substrates and products was conducted 
between 300nm-600nm. Characteristic peaks for wild type AONS were seen at 334nm and 425nm. These 
correspond to the protonated and non-protonated forms of the lysine bound PLP internal imine 
respectively. To investigate this, the imine bond was reduced by incubation of the enzyme with 2mM 









300 	350 	400 	450 	500 	550 	600 
Wavelength (nm) 
Spectra of NaBI-14 reduced and wild type spectra. Wt AONS (121jM) was incubated for 20 minutes with 
2mM NaBH4 at 30°C. The native spectrum is represented by the black line and the reduced spectrum is 
seen in red. 
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The maximum of the imine bound cofactor at 425nm disappears, but the maximum at 334nm increases 
visibly. This maximum is the probable result of reduction of the Schiff base linkage to a single bond 




ESI Mass spectrometry of His6-tagged AONS. The protein was separated from salts in the buffer by HPLC purification with H20/Acetonitrile containing 
0.01% Trifluoroacetic acid on a C5 column. The predicted mass of the protein was 42,619 Da. 
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On addition of L-alanine to the native spectrum, the peak at 425nm becomes less well-defined, and on 
addition of the second substrate, pime!oyl-CoA, to the complex, a maximum at 486nm becomes visible 
(fig 3.3.3). At the same time, a reduction in the absorbance at 425nm suggests conversion of bound L-
atanine into the product. Very little reduction of the L-alanine external aldimine is observed on addition 
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Figure 3.3.3 
Change in the cofactor absorption spectra of E.coli AONS on addition of substrates and product. Spectra 
were acquired at 30°C and pH 7.5. The AONS-PLP complex can be seen in black (lOi.tM); in the presence 
of: 10mM L-alanine (red); 10mM L-alanine and 100i.tM pimeloyl-00A (green); 2mM AONS (blue). 
On addition of the product, AON, to the native enzyme, a clear shoulder can be observed at 520nm 
suggesting the formation of the enzyme-product aldimine. The longer wavelength is predictable on the 
basis of the addition of a ketone function to the chromophore. 
Page 56 
eA4m 3: 	4de'ii4atio'c 4 5 ,  co& ,47tS 
3.3.2 Absorbance spectra of Hisrtagged AONS 
To establish whether there were any differences between the H1s 6-tagged protein and its wild type 
equivalent, the same UV/visible spectrophotometric characterisation was carried out on the His 6-tagged 
protein.. The native spectrum of its holoenzyme also displays characteristic peaks at 334nm and 425nm 
indicating the presence of the imine bound form of the cofactor as before. A series of experiments similar 
to those conducted for wild type enzyme was carried out. They included addition of substrates and 
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Figure 3.3.4 
Change in the cofactor absorption spectra of E.coli H1s6-tagged AONS on addition of substrates and 
product. Spectra were acquired at 30°C and pH 7.5. His6-tagged AONS-PLP complex (6xM): in the 
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presence of: 10mM L-alanine (red); 10mM L-atanine and 100tM pimeloyl-00A (green); 2mM AONS 
(blue). 
In fig 3.3.4, the black line represents the native spectrum, which indicates a slightly higher absorbance of 
the band at 425nm relative to the concentration of protein compared with wt AONS. This band is 
enhanced on addition of L-alanine, but relatively little change is seen in the spectrum of addition of 
pimeloyl-CoA. There is no visible evidence of a quinonoid peak at 486nm on addition of the second 
substrate which contrasts to the behaviour of the wild type enzyme. On incubation of the His 6-tagged 
enzyme with the product, AON, there is a noticeable decrease in absorbance at 425nm and a large band 
appears as a shoulder at 520nm. This is comparable to results obtained with the wt enzyme. Coupled with 
the increase in the product band, there is a decrease in absorbance at 425nm, suggesting depletion of the 
residual enzyme-cofactor complex. Both wild type and His 6-tagged proteins were incubated at different 
pH values. Neither enzyme showed any pH dependency between pH 6.5 - pH 9, suggesting that the PK a 
of the active site lies outside this range. 
3.3.3 Dissociation constant of L-alanine 
The maximum increase at 425nm of the external substrate aldimine was used to determine the 
dissociation constant of the first substrate for His 6-tagged AONS. L-alanine was titrated into the complex 
and the resulting absorbance increase at 425nm was plotted against the substrate concentration in a 
Michaelis-Menton saturation curve according to equation 2. 
AAnm 
AA [L — alanine] = ....................................................................Equation 2 
K + [L - alanine] 
58' 
(aftec' s. eaaae 4 S. coed ,4etS 
This revealed a dissociation constant of 160mM for L-alanine which is lower than the constant obtained 
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Figure 3.3.5 
Titration of 10tM His6-tagged AONS with L-alanine. AONS was mixed with the substrate in 200mM 
potassium phosphate buffer, pH 7.5, and left to equilibrate for 30 minutes at 30°C. Acquisition of the 
spectra was at 30°C and pH 7.5. Titration of AONS with L-alanine. Concentrations are 100iM (pink); 
500j.tM (cyan); 1 m M (blue); 11mM (green); 22m  (red); 55m  (black). 
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3.4 Steady state kinetics of wild type and His6-tagged AONS 
Steady state kinetic assays were performed by means of the coupled assay adapted by Webster et a! (36) 
from the assay to determine kinetic activity of ALAS by Hunter & Ferreira (47). Assays were performed 
at 30°C and data were fitted to Michaelis-Menton saturation curves according to equation 1 (see section 
2.4.1). The steady state rate constants for both wild type and His 6-tagged AONS are summarised in table 
3.1. The turnover of the wild type protein was approximately three fold faster than that for the His 6-
tagged protein, suggesting that the His 6  tag has some effect on the geometry of the active site. 
The binding specificity of His 6-tagged AONS for pimeloyl-CoA is comparable with that for the wild type 
enzyme, as evinced from the K m  data. However, the K m of His6-tagged AONS for L-alanine is 
approximately half that of the wild type. This contrasts to the results of L-alanine titration of the 
modified protein. 
Table 3.2 
Steady state kinetic parameters of E.coli wild type and His6-tagged AONS. Kinetics measurements were 
performed at 30°C, pH 7.5 using the coupled assay. Errors are given in parentheses 
pimeloyl-CoA 	 L-alanine 
AONS 	kat Km kcatIJ(m Km kat/Km 
(s) (j..tIVI) (sIv1T') (mlvi) (s 1 M 1 ) 
Wild type 	0.06(0.01) 25(2) 2400(430) 0.50(0.04) 120(21) 
His6-tagged 	0.02(0.003) 22(2) 909(114) 1(0.2) 20(3.5) 
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An approximate five-fold enhancement in L-alanine binding for the I-lis 6-tagged enzyme, coupled with a 
higher Km  value for this first substrate, may suggest that formation of the external substrate aldimine in 
the tagged protein is more favourable than external aldimine formation in the wild type enzyme. 
Orientation of this aldimine in the His 6-tagged protein, however, may be such that abstraction of the Cc 
proton is hindered. 
The differences in L-alanine binding between the two enzymes, coupled with changes in the steady state 
kinetics; the higher absorption coefficient for the PLP-substrate external aldimine and the absence of a 
visible quinonoid peak on addition of pimeloyl-CoA, suggests that the N-terminal tag may alter the 
functionality of the enzyme. In view of the differences between the wild type and the modified proteins, 
the method of tagging the AONS enzyme for the purposes of mutant purification was discarded. 
3.5 Mutagenesis of wild type AONS 
Several conserved residues in the active site of AONS have been identified (see section 1.2.1). The lysine 
236 residue of the E.coli AONS enzyme forms the internal aldimine Schiff base linkage with the PLP 
cofactor. A lysine residue is crucial in all PLP dependent enzymes thus far investigated (for reviews see: 
(104); (107); (111)). This basic residue was altered by site directed mutagenesis to an alanine residue. An 
oligonucleotide containing 21 bases was designed as the forward primer and incorporated the mutated 
codon with several correct codons either side to allow annealing onto the pUC I 8/bioF template. The 
reverse primer was M13, which anneals to a site on the pUC18 vector approximately lOObp downstream 
of the gene. The megaprimer was approximately 500bp and this was subsequently used as the reverse 
primer to produce the complete gene fragment from the original template, pUC1 8/bioF, and a forward 
primer, FEcoBsp, designed to incorporate an EcoRI and a BspFll restriction site upstream of the gene. 
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Directional ligation of the amplified gene into an EcoRlJBamHI digest of pUCI 8IRBS and subsequent 
transformation of this plasmid into Top 10 One Shot competent cells allowed low-level over-expression 
of the mutant gene. Sub-cloning the gene into the over-expression vector pET 16b was carried out as for 
wild type (see section 3.1.1). Using a similar procedure and a megaprimer of 750bp, a second active site 
residue, histidine 133, was mutated to a phenylalanine residue. 
3.6 Isolation and purification of mutants 
The K236A and H133F mutants were over-expressed and purified according to the original protocol 
developed for wild type AONS. The initial cell pellet was the creamy beige colour of harvested cells and 
not the yellow which can be seen on over-expression of wild type or His 6-tagged AONS. The cell free 
extract containing the mutant enzymes displayed a hint of yellow, but the protein solution did not turn a 
deep yellow until after fractionation with 35% ammonium sulphate. Due to the less basic nature of the 
mutant enzymes, and thus reduced hydrophobicity, they eluted from the first chromatographic column 
with 15% ammonium sulphate. This contrasts to the behaviour of the wild type enzyme, which elutes in 
the latter stages of the gradient at 3% ammonium sulphate. The mutant proteins eluted from the anion 
exchange chromatographic column at 180mM NaCl, in contrast to the wild type which elutes at 260mM 
NaCl. It seemed unlikely, therefore, that the characterisation results of mutant enzymes purified in this 
manner could be affected by any residual wild type enzyme activity. 
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Table 3.3 
Purification table of K236A mutant E.coll AONS. Protein concentration was measured using the method 
of Bradford and specific activity was measured in a coupled assay using 50mM L-alanine and 200DM 
pimeloyl-CoA. 1U AONS represents the transformation of 1 tmol pimeloyl-CoA by 1mg enzyme per 
minute at 30°C 
Purification Step 	Volume Protein Specific Yield Purification 
(ml) (mg/mi) activity (U) (%) fold 
Crude extract 60 49 -- -- -- 
35% ammonium sulphate 62 39 0.01 82 1 
65% ammonium sulphate 35 39 0.013 46 1.3 
Hydrophobic interaction 150 3.3 0.017 17 1.7 
Anion exchange 50 2.4 0.035 4 3.5 
Yield is approximately 15mg/I of K236A of ~! 95% purity as estimated by SDS PAGE. The specific 
activity of the purified mutant protein was approximately one tenth of that observed for wild type AONS. 
Yield was approximately 11mg/mi and the purification factor was similar to that obtained for the wild 
type enzyme. Protein purity was 90% as judged by SDS PAGE and specific activity was one fifth of that 
observed for the wild type enzyme. 
On the basis of visible spectroscopy, it appeared that a small amount of PLP cofactor remained bound to 
the K236A mutant throughout the purification and freezing process. However, the Hi 33F mutant lost all 
of its PLP cofactor during anion exchange chromatography and subsequent concentration of the enzyme. 
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Table 3.4 
Purification table of H133F mutant E.coli AONS from expression in an E.coll host. Protein concentration 
was measured using the method of Bradford and specific activity was measured in a coupled assay using 
50mM L-alanine and 200.iM pimeloyl-00A. 1U AONS represents the transformation of ljimol pimeloyl-
00A per minute at 30°C 
Purification Step 	Volume 	Protein 	Specific 	Total 	Yield Purification 
(ml) 	(mg/ml) 	activity 	activity 	(%) 	fold 
(U/mg) 	(U) 
Crude extract 45 47 -- -- -- -- 
35% ammonium sulphate 45 35.5 0.012 19.2 100 1 
65% ammonium sulphate 25 13 0.047 15.3 80 3.9 
Hydrophobic interaction 100 1.7 0.06 10.2 53 5 
Anion exchange 45 2 0.075 6.75 35 6.25 
3.7 Physical Characterisation of the K236A and H133F mutants 
Attempts to dialyse PLP into both mutant proteins were successful, and a maximum could be seen at 
425nm for K236A. Upon washing of the protein with potassium phosphate buffer, pH 7.5 and no 
additional PLP, the aldimine linkage was lost in the H133F protein, suggesting that the mime bond is not 
stable in the absence of the basic histidine residue. 
The absorption coefficient of the PLP bound form of K236A was measured at c1856 I mol' cm', a 
figure four fold lower than the corresponding coefficient for wild type AONS (see section 5.2). This 
suggests that cofactor binding has been considerably reduced by the removal of the lysine residue, but 
may also indicate that the cofactor may be held in the active site by other residues. 
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An approximate size was estimated for the mutant proteins by SDS PAGE analysis using wild type 
AONS as a reference and was necessary during the purification process. The mass of the K236A and 
H133F proteins was identified with ESI mass spectrometry (table 3.6). 
Table 3.5 
ESI Mass spectroscopy of K236A and H133F mutant AONS. The protein was separated from salts in the 
buffer by HPLC purification with H 20/Acetonitrile containing 0.01% Trifluoroacetic acid. 
Mutant AONS 	 Predicted (Da) 	 Measured (Da) 
K236A 	 41,407.15 	 41,413.2 
H133F 	 41,474.3 	 41,478.6 
3.8 UV/visible Characterisation of pyridoxal-5'-phosphate 
As has been noted above, the two AONS mutants lose much of their ability to bind the cofactor PLP. For 
this reason, UV/visible spectroscopy was carried out on a I 00tM PLP solution to establish the nature of 
binding by the free molecule. The results of this characterisation were then used to assess whether the 
changes in absorbance observed on the visible spectra of the mutant enzymes is due to the protein active 
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Figure 3.8.1 
Titration of lOOjiM PLP with potassium phosphate The PLP aldehyde was incubated for 20 minutes at 
30°C and pH 7.5. Ionic strengths: 5mM potassium phosphate (black); 200mM (red); 1M (green) 
The spectrum of PLP displays characteristic peaks of the aldehyde at 390nmn and the protonated form of 
this bond at C 4  at 330nm (129). As the ionic concentration of the potassium phosphate buffer increases, 
the absorbance maxima of the PLP solution can be seen to change. The absorbance at 390nm increases 
with increasing ionic strength, with a corresponding decrease in absorbance at 330nm. An isosbestic 
point can be seen at 360nm, indicating an equivalence point between the protonated and deprotonated 
forms of the aldehyde. 
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A solution containing free PLP was also titrated against L-alanine in order to establish the behaviour of 
the free molecule with the first substrate of the AONS catalysed reaction. The salt concentration was held 
constant at 160mM for each titration. The imine bond formed between PLP and L-alanine is visible as an 
absorbance at wavelength 425nm. The absorbance maximum at 340nm corresponds to the form of the 
molecule protonated at C4.  and decreases as the imine bond is formed. The dissociation constant (K,) of 
L-alanine from the free cofactor molecule is 9mM. This is a ten-fold increase on the dissociation 
constant measured in the native enzyme (36), indicating that the active site presents a more favourable 
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Figure 3.8.2 
Titration of 100.tM PLP against L-alanine. The cofactor molecule was incubated with the amino acid for 
20 minutes at 30°C and pH 7.5. L-alanine concentrations 100mM (green); 50mM (blue); 25mM (cyan); 
10mM (pink); 5mM (yellow): 1mM (brown) 
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Finally, in order to establish the characteristic spectra of PLP under various acidic or basic conditions, 
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Figure 3.8.3 
pH titration of lOOp.LM PLP at 30°C. Free PLP was incubated in 1M HEPES at the relevant pH value for 30 
minutes and the spectrum recorded. pH 9 (black); pH 8.4 (red); pH 8.1 (green), pH 7.8 (blue); pH 7.6 
(cyan); pH 7.3 (orange); pH 6.9 (pink) 
The absorbance of the aldehyde bond at 390nm is maximised as the solution becomes more basic. There 
is also a decrease in absorbance at 330nm in this environment. As the solution changes slowly towards a 
more acidic pH value, a decrease in absorbance at 390nm can be observed. There is, however, no definite 
trend detected at 330nm. These results suggest that the basic environment allows for maximum aldehyde 
concentration at C 4 ,  and an alteration in these conditions slowly reduces this band as electrophilic attack 
49e 6ff  
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by the solvent occurs at this position. This spectral change is not observed in the native enzyme, 
suggesting a constant pH value is retained in the active site. 
3.9 UV/visible Characterisation of K236A and H133F mutants 
All UV/visible spectroscopy characterisations of mutant and wild type proteins were carried out at a 
maximum salt concentration of 200mM. 
3.9.1 Absorbance spectra of K236A AONS 
Prior to spectroscopic analysis, the protein was dialysed against 20mM potassium phosphate buffer, pH 
7.5 containing 100tM PLP and the excess PLP was subsequently removed by exhaustive washing with 
20mM potassium phosphate buffer. Cofactor absorption peaks are visible at 330nm and 425nm 
respectively for the holoenzyme. On addition of the first substrate, there is a shift in the chromophore 
absorbance to the slightly shorter wavelength of 420nm, and the peak at 330nm disappears entirely. 
Thus, the UV/visible spectrum of the K236A AONS mutant shares all the characteristic peaks seen in the 
spectrum of wild type AONS. 
The visibility of a peak at 425nm in K236A suggests the presence of an imine bond within the active site. 
Since the free PLP molecule aldehyde has an absorbance at 390nm, an absorbance at a longer wavelength 
suggests either a possible condensation reaction with another basic residue within the active site as the 
lysine is no longer available for such binding and alanine lacks the amino group found as part of the 
lysine residue and thus cannot form an imine bond with PLP; or a shift caused by some other 
environmental factor. 
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The spectrum of the K236A-L-alanine bound form does not change on addition of up to 300.tM 
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Figure 3.9.1 
Absorbance spectra of 81.iM K236A holoenzyme and on incubation with L-alanine at 30°C for 20 minutes. 
Spectra were acquired at 30°C and pH 7.5. K236A holoenzyme (black); in the presence of 1 m M L-alanine 
(red); in the presence of 100mM L-alanine (green) 
As has already been observed, the 330nm absorbance peak disappears from the K236A spectrum on 
addition of L-alaniiie. Titration of the mutant protein confirms this, as larger concentrations of the amino 
acid substrate do not affect this result and neither do they produce a change in the absorbance at 420nrn, 
suggesting that this absorbance may not be due to the external aldimine linkage, but rather a shift in 







300 	350 	400 	450 	500 	550 	600 
eA4 3.. 	t44 4 E. 
Wavelength (nm) 
Figure 3.9.2 
Titration of lOi.tM K236A with L-alanine at 30°C and pH 7.5. The protein was incubated for 20 minutes at 
30°C. L-alanine concentrations: 200mM (red); 100mM (green); 50mM (blue); 10mM (cyan); 1mM (pink) 
The protein was titrated with concentrations of L-alanine up to IM without any noticeable changes in the 
spectrum. Thus it was impossible to calculate a dissociation constant for L-alanine-PLP complex of this 
mutant and the first substrate, but negative results would suggest the absence of the lysine residue renders 
the active site incapable of binding of L-alanine alone. However, identical spectra were obtained on 
repetition of this titration in the presence of 200iM pimeloyl-CoA, suggesting that addition of the second 
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3.9.2 Absorbance spectra of H133F AONS 
The H133F mutant protein was prepared in the same way as K236A AONS. The UV/visible spectrum of 
the washed protein displays no absorbance maxima between 330nm - 430nm, suggesting that there is no 
imine binding of the cofactor within the active site. The absence of a maximum at 390nm also indicates 
that the aldehyde form of the cofactor is not present. 




Absorbance spectra of 101.iM H133F apoenzyme and on incubation with L-alanine at 30°C for 20 minutes. 
Spectra were acquired at 30°C and pH 7.5. H133F apoenzyme (black); in the presence of 2.tM PLP and 
1 m M L-alanine (red); in the presence of 21.tM PLP and 100mM L-alanine (green) 
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On addition of 2iM PLP, a characteristic peak at 390nm was visible. This did not shift on addition of L- 
alanine concentrations below 8mM, suggesting dissociation of the amino acid substrate from PLP was 
not affected by the mutated enzyme. At elevated L-alanine concentrations, there was a red shift in the 
absorption peak to a more characteristic 420nm wavelength. Addition of pimeloyl-CoA did not affect the 
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Figure 3.9.4 
Titration of 10iM H133F with L-alanine at 30°C and pH 7.5. The protein was incubated for 20 minutes at 
30°C with 2M PLP and various L-alariine concentrations: 100mM (red); 50mM (green); 10mM (blue); 
5mM (cyan); 1mM (pink) 
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The absorbance peak shifts from 390nm to 420nm on addition of L-alanine concentrations exceeding 
10mM, but subsequent titration increases absorbance at the longer wavelength. The peak at 330nrn is 
visible at all concentrations of L-alanine, but is only enhanced on addition of larger quantities of the 
amino acid. At lower concentrations, results would suggest titration of the PLP cofactor as if it were a 
free molecule. However, enhanced concentration of the substrate seems to induce a change in the active 
site, and subsequently the external aldimine bond. 
3.9.3 pH studies on K236A and H133F AONS 
Studies into the pH of the active site of the mutants proved inconclusive as both proteins were unstable in 
low salt buffers of 50mM HEPES; 50mM CAPS; 50mM CHAPS and 10mM Bis-Tris-Propane. This may 
suggest that a metal ion may be required for mutant protein stability, however, addition of monovalent 
cations (Na 1 , K) as sodium and potassium chloride salts, did not reverse this instability, even at very low 
concentrations. 
3.10 Steady State Kinetic Characterisation of K236A and H133F 
mutants 
The coupled assay was used to test the activity of PLP alone and indicated that the cofactor was unable to 
catalyse the thioester bond cleavage in the absence of the enzyme. 
3. 10.1 Steady state characterisation of K236A A ONS 
The Michaelis constants for the steady state kinetics of K236A were calculated for pimeloyl-00A using 
the coupled assay in the presence of 200mM L-alanine. Constants for the amino acid substrate could not 
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be obtained as the enzyme displayed no significant difference in activity at any concentration, suggesting 
an alteration in binding of L-alanine. In fact, the enzyme displayed residual activity in the absence of L-
alanine suggesting it may be possible that the K236A-L-alanine complex is acting as a hydrolase on the 
pimeloyl-00A substrate. 
Table 3.6 
Steady state kinetic constants for K236A AONS E.co!i. Constants were measured at 30°C and pH 7.5 and 
fitted to a Michaelis-Menton saturation curve. 
pimeloyl-CoA L-alanine 
AONS 	kcat Km 	kat/Km Km 	kcat/Km 
(sd ) (j.tIVl) 	(s'Ivr') (mlvi) 	(sM') 
wild type 	0.06(0.0 1) 25(2) 	2400(430) 0.50(0.04) 	120(2 1) 
K236A 	0.001(7F 5 ) 45(11) 	22(3) -- 	 -- 
There is a significant decrease in the turnover of the lysine mutant enzyme. This sixty-fold reduction in 
catalytic activity suggests that cleavage of the thioester bond of the pimeloyl-CoA substrate does not 
occur in an efficient manner. Binding of this substrate is not significantly different to wild type binding 
of pimeloyl-00A, suggesting that access for this molecule is unhindered. The inability to obtain constants 
for the binding of L-alanine may indicate inaccurate or inefficient binding of the substrate with the 
cofactor. 
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3.10.2 Steady state characterisation of H133F A ONS 
The PLP loaded form of the H133F AONS mutant was prepared by dialysing the protein for one hour in 
20mM potassium phosphate buffer, pH 7.5 containing 1001tM PLP. Assays were carried out using the 
coupled assay protocol developed for wild type E.coli AONS. 
Table 3.7 
Steady state kinetic constants for H133F AONS E.coIi. Constants were measured at 30°C and pH 7.5 and 




AONS 	kat Km kat/Km Km kcatll(m 
(si) (1i,M) (SAM') (ml\4) (s'M) 
wild type 	0.06(0.01) 25(2) 2400(430) 0.50(0.04) 120(21) 
H133F 	0.001(6E 5) 46(3) 22(1) 15(3) 0.06(0.009) 
There is a clear reduction in catalytic binding and efficiency observed in the H133F mutant. The turnover 
of pmieloyl-00A, as evinced from the k values, suggests that activity of the enzyme has been reduced 
significantly by sixty-fold. This reduction results from a vast, two thousand-fold decrease in binding 
specificity of the enzyme for L-alanine. Binding efficiency of the amino acid is also much reduced, a 
thirty-fold decrease, which compares with a K m  constant for pinieloyl-00A barely twice that of the wild 
type enzyme, suggesting that binding of the second substrate remains relatively unaffected by the 
mutation. This results in a binding specificity for the second substrate of only one hundred fold lower 
than observed for the wild type enzyme. 
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Discussion 
A His6-tagged fusion of E.coli AONS was constructed and over-expressed. It displays similar activity to 
the WI enzyme but the absence of a visible quinonoid peak on incubation of the external substrate 
aldimine complex with pimeloyl-00A suggests differences in stability of this intermediate. This 
difference in quinonoid formation is also reflected by the decrease in catalytic activity of the His 6-tagged 
protein. The lower specificity seen in His 6-tagged AONS for its substrates may be a result of decreased 
access to the active site of the enzyme caused by the polyhistidine adduct at the N-terminal of the protein. 
Structural studies (37) show that the N-terminal region is characterised by an cc-helix motif in close 
proximity to the C-terminus responsible for closure of the active site on addition of the product, AON 
(36), and possibly on addition of the substrates (37) as has been noted for several other enzymes (see 
reviews 107; 111 and references therein). The presence of a long polyhistidine tag in this region may 
sterically hinder the substrates as they enter the active site, thus reducing binding efficiency of the 
enzyme. The absence of a pH dependency within the active site of the His 6-tagged enzyme suggests that 
closure may well occur on binding of the substrates. 
While the polyhistidine fusion was chosen to enable simple and accurate purification of the mutant 
proteins without contamination of the wild type enzyme, the results of kinetic studies make it obvious 
that this strategy had to be discarded. 
Both mutants involved replacing a basic residue with a uncharged amino acid and this altered the p1 of 
the enzyme. This was evident on purification of the mutant proteins by FPLC. The mutant enzymes elute 
from the initial hydrophobic interaction columns at a significant fraction interval from where the wild 
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type enzyme is seen to elute. This is repeated for the anion exchange column, thus ensuring that any 
residual wild type enzyme is not included in the final protein solution. 
Whilst characterisation of the PLP spectra has already been described (129) it was necessary in this study 
to show the activity of the free PLP molecule under the conditions required for assay of the mutant 
AONS proteins. These were especially important when considering the activity of the histidine mutant. 
The relative lack of effect of the ionic concentration at 200mM and below indicated that the cofactor was 
not altered at different concentrations of buffer. Although the lower concentration favours a possible 
protonated aldehyde form, seen at 340nm, there is no evidence to suggest that this alters the species 
bound within the active site. There is also no evidence to indicate that the species in the active site are pH 
dependent, unlike the free PLP molecule. This is further evidence to suggest that there is closure of the 
protein molecule to the surrounding solvent. 
There is a ten-fold increase in L-alanine dissociation constant for the free PLP imine compared to that 
found in the wild type E.coli AONS enzyme. This is a significant difference, and indicates that the 
residues involved in the active site of the enzyme contribute to lowering this constant and thus enhancing 
catalytic activity. This is an example of the Circe effect described by Cordes and Jencks (110) which 
suggests that the intrinsic affinity of an enzyme for its substrates can be increased in comparison to the 
free molecule. The lysine mutant of aspartate aminotransferase is a good example of this (130). K258A is 
active on addition of primary amines and lowers the activation energy of external aldimine formation by 
reducing the binding energy of the cofactor and the amino acid substrate. 
There is much evidence to suggest that the lysine resithie invol'edin cofactor binding is critical for 
catalytic activity in PLP enzymes as it is involvedincofactor binding and general base catalysis of C 
proton abstraction (48); (50); (130-134). Mutatiowou1tresichie to alanine results in an enzyme with 
little or no activity. The lysine to alanine mutation otbecorresp*n4ing residue in E.coli AONS results- Pag 
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in a protein with reduced activity. Turnover is reduced sixty-fold on comparison with wild type AONS 
and binding of substrates is inefficient. On purification, the enzyme appears to display the internal 
cofactor aldimine, although the lysine residue is absent. This could be a result of binding of the cofactor 
to another basic residue within the active site. Alternatively, PLP may be bound to an amino group taken 
up by the protein during the purification process in a similar manner to that observed for O-acetylserine 
sulthydrylase from Salmonella typhimurium (135). Structural studies have shown that the cofactor is 
covalently bound to a methionine residue in the active site and stabilised by an "asparagine loop" which 
moves lÀ to make this bond. This loop corresponds to the "glycine rich loop" (45) observed in the ALAS 
sequence and alignment of the asparagine loop with the GIGSGGSG region in E. coil AONS suggests it 
is the same motif. The cofactor within this enzyme tilts so that the C 4 , atom is directed towards the 
entrance to the active site. A similar configuration in the K236A E.coli AONS mutant may suggest an 
explanation for the apparent absence of an absorbance maximum corresponding to a quinonoid 
intermediate. Observed catalytic activity, however, suggests that such an intermediate must be created in 
order to cleave the thioester bond of the pimeloyl-CoA. The formation of this intermediate therefore 
indicates that a proton is abstracted from C Residual activity of this enzyme on the absence of L-alanine 
suggests confirmation of this theory. The absence of a significant change in K d of L-alanine from this 
mutant indicates that concentration is not necessarily relevant to L-alanine binding within the active site. 
The disappearance of the peak at 330mn on addition of this substrate, however, suggests that it becomes 
chemically involved in the interaction already present in the active site of the protein, and its addition 
results in a thermodynamic unfavourability for the protonated form of an imine bond. 
Studies into the structural conformation of murine cytoplasmic serine hydroxymethyltransferase have 
already shown intermediate states in the chemical pathway of its catalysis (136). The complexity of the 
AONS mechanism resulting from the K236A mutant suggest that such studies would be helpful to 
understanding the function of this protein. 
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Although mutation of the lysine residue seems to have a profound effect on the chemistry involved at the 
active site of AONS, mutation of the H133 residue has a far more dramatic effect on the binding of the 
PLP cofactor. A substitution of this basic residue for a non-polar residue results in such weak binding of 
the cofactor, that the enzyme is no longer able to retain the cofactor within its active site. Spectral 
analysis of the enzyme on addition of PLP indicates that the cofactor is present in the aldehyde form, 
suggesting that misalignment of PLP results in a loss of ability of the lysine residue to covalently bind to 
the cofactor. 
It has already been noted that the H133 residue swings through 1800 on addition of PLP in order to lie in 
parallel with the pyridine ring of the cofactor (37). The loss of positive charge on this residue may inhibit 
this realignment and subsequently sterically hinder correct configuration of the cofactor for formation of 
the aldimine linkage. Higher concentrations of L-alanine restore external aldimine formation, suggesting 
that PLP acts in a similar manner to the free molecule. The observation of kinetic activity indicates 
abstraction of the C. proton and subsequent nucleophilic attack of the pimeloyl-CoA thioester bond, 
leading to the release of free CoASH. 
There have been few studies into the effect of mutation of this conserved histidine residue. Alteration of 
this base in sheep liver cytosolic serine hydroxymethyltransferase (137) resulted in an enzyme with very 
little bound PLP. The H167R mutant of E.coli glutamate decarboxylase, shows a tighter binding of PLP 
(138). However, an absence of PLP binding was noted for this enzyme on mutation of the residue 
corresponding to the H207 residue in E.coli, suggesting cofactor binding may occur in a different manner 
in this enzyme. 
Observation of similar activity for both mutants suggests that catalytic efficiency is reduced to the same 
degree on alteration of either residue and indicates that other residues in the active site are capable of a 
certain amount of compensation of function. Specificity for the second substrate is affected the least by 
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these mutations and although data indicates release of CoASH, further steps in the catalysis reaction 
cannot be monitored and thus it is possible that full catalysis may cease at a later stage. Results gained 
from observation of the activity of the histidine mutant would suggest that remote hydrogen bonding is 
necessary to anchor the PLP cofactor, and elimination of the lysine residue may inactivate the enzyme. 
A section of this work is incorporated into the publication that forms appendix II. Permission to include 
this paper was granted from the relevant authors. 
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Chapter 4 
Introduction to Thermophiles 
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4.1 Extremophiles 
In the last few decades, microorganisms have been isolated from extreme locations, which were once 
thought to be incapable of sustaining life. These so-called extremophiles were initially assigned to a 
separate bacterial kingdom, the Archaebacteria. More recently, however, Eubacteria native to 
extreme environments have been isolated. Organsims found in such surroundings are generally 
classified into six groups as shown in table 4.1. 
Table 4.1 
Subgroup classification of extremophiles identified to date. (Adapted from 139) 
Extremophile Location Optimum growth 
Barophiles Deep sea vents High pressures 
Halophiles Salt lakes High salt concentrations 
Thermophiles Geothermal locations Temperatures above 50°C 
Psycrophiles Arctic waters Temperatures below 0°C 
Acidophiles Acidic, sulphurous springs Acidic conditions 
Alkalophiles Alkaline lakes Alkaline conditions 
Extremophiles are chemolithoautotrophs and utilize inorganic redox reactions to convert carbon and 
nitrogen compounds in their environment into energy sources. It is now widely accepted that life on 
earth was initiated in such hostile environments by these organisms (140). 
The protein catalysts of extremophiles are unique in that they are able to withstand the various 
pressures of their environment, and thus the term "extremozymes" has been coined to define them. 
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4.1.1 Thermophiles 
The largest class of extremophiles, containing to date twenty-seven genera of Archaea and three 
Eubacterial genera (Thermotoga, Hydrogenobacler and Aqufex), are thermophiles. Thermophiles 
grow at an optimal temperature above 50°C, although some of these organisms belong to a 
thermophilic subgroup of hyperthermophiles (141), where growth conditions of these latter 
organisms are generally between 80-106°C. The most heat stable of all organisms found to date is 
Pyrolobu.fumarii which grows optimally at 113°C (142). 
The universal phylogenetic tree separates the three main kingdoms of Archaea, Bacteria and 
Eukarya. Located about the root of the stem on the bacterial branch are the three hyperthermophilic 
genera Thermatoga (optimal growth temperature: 95°C), Hydrogenobacter (optimal growth 
temperature 90°C) and Aqufex (optimal growth temperature: 90°C) (fig 4.1.1). Stetter (143) 
suggests that the deeper along the branch the hyperthermophile lies, the hotter their optimum growth 
environment. 
The lateral transfer of genes from Archaea to Bacteria has been suggested by Nelson on the basis of 
detailed investigation of the genome from Thermotoga maritima, a hyperthermophilic bacterium 
isolated from heated marine sediment from Vulcano, Italy (144). In T.maritima, 81 archeal like 
genes are clustered in 15 regions throughout the genome and 24% of the genome displays genes 
similar to archeal genes. A further 5% of the genes have analogues only in other thermophiles. 
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The universal phylogenetic tree of life. (Taken from 140). 
To date, the majority of hyperthermophiles have been isolated from thermal vents at Yellowstone 
National Park, USA (146), which claims to house 80% of the world's geysers and 60% of its 
geothermal features. One organism, Thermophilu.s aqualicus, was isolated from Yellowstone in 
1965. The purification of its DNA polymerase has proved catalytic in the progress of biotechnology. 
T.aquaticus DNA polymerase (Taq) is now the major enzyme used in the Polymerase Chain Reaction 
(PCR). Other extremozymes have made their way into industrial processes and many biotechnology 
companies are furthering this trend, over-expressing extremophilic proteins in E.coli or Bacillus sp. 
(147). 
;kccus 
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4.2 Protein Thermostabilty 
Cell components of thermostable organisms must be able to withstand high temperatures, and 
research has shown that membranes of thermophiles are composed of novel ether lipids, dissimilar to 
the ester lipids common in mesophilic Eubacteria. A unique DNA type I topoisomerase has also been 
isolated from thermophiles (148). Reverse gyrase causes positive supertwists in the nucleotide 
molecule which are further stablised in Archaea by histones (149), similar to a feature mechanism 
utilised in eukaryotes. The role of heat shock proteins in thermophiles is still at an early stage of 
investigation (143). 
Protein thermostability cannot be attributed to any single modification and it is not obvious from the 
secondary sequence how this is achieved. Comparison studies of thermophilic and mesophilic 
enzymes, however, has suggested possible mechanisms of heat stability (140) (150-153). 
4.2.1 Amino acid composition 
Hyperthermostable proteins are composed of the same 20 amino acids found in the composition of 
mesophilic and less thermostable proteins. At elevated temperatures, however, certain residues are 
more heat labile than others, and cysteine, asparagine and glutamine have the shortest half lives 
(15 1) as they tend to undergo deamidation or oxidation. It is therefore not suprising that there is a 
general decrease in the relative percentages of these amino acids within the primary structure of 
proteins from hyperthermophiles, which show an increase in percentage of the more robust, charged 
residues such as aspartate and glutamate. 
Tighter amino acid packing is a feature of some hyperthermophilic proteins structures (152) (154- 
156). Higher levels of isoleucine and alanine have been suggested to allow this within the protein 
molecule (157). An increase in proline residues has also been suggested (158) to enhance loop 
P49e 96 
ehm 4: Tt'øwdaetio.t to 7uode4 
stability. This is demonstrated particularly well in thermostable aspartate aminotransferase (159) 
which displays an elevated proline content. 
4.2.2 Hydrophobic packing 
An efficiently packed hydrophobic core is a feature of most globular proteins, although this feature is 
generally observed in enzymes from organisms growing below 100°C (140) (160-162). Hydrophobic 
interactions are found at the subunit interface of glutamate dehydrogenase from T.mariiima (163) 
although the same enzyme from P.furiosus (164) displays an intricate ion-pair network between 
subunits. Privalov & Gill (165) calculated Gibbs free energy values for hydrophobic interactions, but 
their results proved inconclusive, and it remains unclear whether such interactions are weakened at 
elevated temperatures. 
4.2.3 Ionic Networks 
Use of ion-pair networking within the macromolecule is a common strategy for stabilising heat stable 
proteins. Perutz &Raidt in 1975 (166) first proposed this on the basis of ferredoxin and haemoglobin 
studies, and an increase in charged residues is seen in many primary sequences of proteins from 
hyperthermophiles. Ionic interactions are more stable than the hydrophobic variety, and are not 
disrupted by alterations to the structure of water, which is compromised at higher temperatures. They 
are generally found on the surface, or solvent exposed parts of the molecule (140). 
Ion-pair networks consisting of up to 18 residues (163) have been the most commonly observed 
difference between mesophilic and thermophilic protein structures. Comparisons of citrate synthase 
(154), glutamate dehydrogenase (163) and xylanase (156) from both thermophilic and mesophilic 
organisms has identified an increase in ion-pair networking within the heat stable molecules. The - 
glycosidase from S.solfataricus (167) also displays an increase in these networks. Studies into other 
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proteins, however, have suggested that it is the position of certain bonds within the network, and not 
the network itself that is responsible for increased stability. Verification of this in both archea and 
bacteria is suggested by the results of mutagenesis studies of glutamate dehydrogenase from 
Pyrococcus furiosus (168), D-glyceraldehyde-3-phosphate dehydrogenase (169) and indole-3-
glycerol phosphate synthase (170) both from T. maritima. 
4.2.4 Subunit Association 
Denaturing of the enzymes proceeds with unravelling of the monomeric subunit, thus proteins that 
function as oligomers must employ a strategy to retain the integrity of conformation. Ionic networks 
are increased at subunit interfaces and cavities are reduced in number in many of the proteins studied 
(163-164) (171). 3-gIycosidase displays an unusually large number of solvent molecules buried in 
hydrophilic cavities at the core of the protein (167). It has been suggested that these cavities aid the 
thermostability of the protein by resistance rather than rigidity. In the case of citrate synthase from 
P.furiosus, the carboxy terminus of one monomer interacts with the surface of the other monomer 
(140). This phenomenon is not found in the mesophilic enzyme from pig (154). The indole-3-
glycerol phosphate dehydrogenase form Sulfolobus solfactaricus (172) is a monomer at 90°C. An 
increase in hydrophobic interactions within the molecule, coupled with an increase in helix capping 
have been observed to contribute to the stability of this protein. The enzymic structure is a TIM 
barrel and unlike its mesophilic E.coli counterpart which has one helix, the S. solfactaricus enzyme 
has two helices before the first 13-strand. Both are bound by ionic interactions. 
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4.2.5 Structural Changes 
Some proteins are observed to have minor structural changes compared to their mesophilic 
counterparts. The most common alteration is a reduction in the size of loops, resulting in closer 
packing of the protein (154) (171). Observations have also identified proteins with a reduced N-
terminal helix (154) (164), although mesophilic citrate synthase enzymes also display a smaller N-
terminal helix region, possibly suggesting that this may be a result of phylogenetic diversity (160) 
and not necessarily thennostability. Other enzymes may retain their N-terminal helix, but protect it 
from degradation by capping it with an acidic amino acid residue (see section 4.2.4). 
In order to find a general strategy for protein thennostability, Szilágy & Závodszky (153) compared 
the 3D structures of 64 mesophilic and 29 thermophilic proteins, representing 25 different families. 
They discovered only one key element, common to all thermophiles, an increase in ion pairs. Other 
strategies were observed as trends, and the number of hydrogen bonds and buried cavities did not 
necessarily increase with increasing temperature. These findings conflict, however, with research 
conducted by Vogt et a! (173), which suggests that hydrogen bonding may be responsible for the 
general stability of therinophilic proteins. Szilagy & Závodszky also observed that different protein 
families were also observed to employ different strategies for heat stability. 
4.3 Activity in thermophiles 
It has already been established that enzymes from hyperthermophiles are active at high temperatures, 
and indeed many show a denaturation half life of several hours at 100°C (142) (164) (174). There 
have, however, been far fewer kinetic characterisations of isolated thermostable enzymes to compare 
with their mesophilic counterparts. Sadly, many comparisons and conclusions have been made on the 
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basis of sequence homology rather than protein density. However, there are a few definitive studies 
which provide some data. In general, catalytic activity seems to increase with elevated temperatures. 
The activity of indole-3-glycerol phosphate synthase from S.solfataricus (172) is twenty-fold higher 
at 60°C than the rate observed at 25°C (170). This observation is reflected in the activity of indole-3-
glycerol phosphate synthase from T. maritima which increases 3 fold on elevation of temperature 
from 25°C to 60°C. In contrast, the V, values of citrate synthase are similar for the mesophilic 
enzyme in pig at 37°C (281L23); the thermophilic enzyme from Thermoplasma acidophilum at 60°C 
(100±14) and the hyperthermophilic enzyme of P.furiosus at 90°C (226±12) (154) (160) (175), 
suggesting there is a possible catalytic penalty to be paid for this enzyme. 
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4.4 Aims of this Project 
The sequencing and subsequent annotation of the genome of Aqufex aeolicus (33) revealed the four 
conserved genes of the biotin biosynthetic pathway contained in this hyperthermophilic organism. In 
an attempt to further characterise the differences between mesophilic and hyperthennophilic 
enzymes, the bioF gene was cloned and the resulting protein AONS over-expressed. 
Hyperthermophilic AONS from A.aeolicus is a 42,306 Da protein present in its active form as a 
dimer. The aim of this project was to obtain milligram quantities of AONS for characterisation by a 




Characterisation of AONS from 
Aquifex aeolicus 
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5.1 Isolation and Purification 
The A.aeolicus bioF gene was successfully amplified from the A.aeolicus genomic DNA template by 
PCR using forward and reverse primers (see section 2.3.5). To facilitate cloning of the gene, the second 
amino acid codon was altered from the original serine encoding codon to a glycine in the forward primer, 
allowing incorporation of an NcoI site at the beginning of the gene. Initial cloning of the amplified 
fragment was achieved by ligation into a Ncol/BamHI digest of pUCI8. From this high copy number 
plasmid, designed to allow production of further quantities of the gene, the bioF fragment was excised at 
the Ncol/Baml-Il sites at the 5' and 3' termini respectively and directionally sub-cloned into pET l6b, an 
E.coli ampicillin resistant expression plasmid containing an IPTG inducible T7 promotor. 





The initial clone of the b,oF gene was sub-cloned into the ampicillin resistant expression vector pET16b 
using a Ncol/BamHl digest of both plasmid and gene fragment. In pET16b, the gene is under the control 
of the powerful 17 IPTG-inducible promotor. 
Pa9e 93 
e(4fte 5: 	 4 ,'61tS 	,1x 4e'6 
The pETl6b/bioF plasmid was transformed into HMS 174 (DE3) cells which were allowed to grow until 
approximate mid log phase, (OD 1). Protein production was induced by addition of a final 
concentration of 1mM IPTG for three hours and cells were harvested (see section 2.2.2). Disruption of 
the cells removed cell debris and heat fractionation of the cell free extract resulted in precipitation of the 
majority of host E.coli proteins. An initial heat step fractionation was carried out at 60°C to allow 
precipitation of the most heat labile host proteins. After trials, a subsequent 80°C fractionation step was 
introduced to remove the more stable proteins from the extract. Heat fractionation was carried out in two 
stages to avoid a general precipitation of all proteins at the higher temperature, since initial studies 
indicated that a reduced yield of A.aeolicus AONS was obtained after only one temperature jump. 
Denaturing proteins in this manner also ensured that any AONS produced naturally by the E.coli host 
strain was removed from the solution as E.coli AONS does not survive temperatures greater than 60°C 
(36). 




SDS PAGE gel (Invitrogen) of A.aeolicus AONS purification. Lane 1 - Standards; Lane 2 - Crude extract; 
Lane 3 - Anion exchange; Lane 4 - 60°C; Lane 5 - 80°C. Standards are: Myosin (200kDa); 3 
galactosidase (1 16.3kDa); Phosphorylase b (97.4kDa); Bovine serum albumin (663kDa); Glutamic 
dehydrogenase (55.4kDa); Lactate dehydrogenase (36.5kDa); Carbonic anhydrase (31 kDa); Trypsin 
inhibitor (21.5kDa); Lysozyme (144kDa); Aprotinin (6kDa); Insulin B chain (3.5kDa); Insulin A chain 
(2.5kDa) 
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The resulting heat treated fractions were passed down an anion exchange column and eluted using a 
linear gradient of 0-1 M NaCl. Homogenous AONS was recovered at 260mM, the same salt concentration 
at which E.coli AONS is observed to elute, suggesting that both proteins have a similar affinity for the 
column and thus a similar ionic strength. This confirms the computational prediction of similar p1 values 
for both proteins4 . 
Table 5.1 
Purification table of A.aeolicus AONS from expression in an E.coll host. Protein concentration was 
measured using the method of Bradford (120) and specific activities were measured in a coupled assay 
using 50mM L-alanine and 2001LM pimeloyl-00A. 1U AONS represents the transformation of 11.imol 
pimeloyl-CoA per minute at 30°C 
Purification Step Volume 	Protein 	Specific 	Total 	Yield 	Purification 
(ml) 	(mg/ml) 	activity 	activity 	(%) 	fold 
(U/mg) 	(U) 
Crude extract 	40 	75 	 -- 	 -- 	 -- 	 -- 
60°C fraction 	35 	68 	0.02 	47.6 	100 	1 
80°C fraction 33 39 0.03 38.6 81 1.5 
Anion exchange 30 1.8 0.7 37.8 79 35 
To ensure that the heat step did not result in modification of the enzyme, purification was also carried out 
using a protocol previously developed for E.coli AONS (36), involving ammonium sulphate fractionation 
followed by hydrophobic interaction and subsequent anion exchange chromatography. All purification 
steps were carried out at room temperature, as purification on ice or at 4°C resulted in denaturation of the 
A.aeolicus enzyme. There proved to be no noticeable difference in steady state kinetic activities or crystal 
Calculated values are 6.63 and 6.77 for the E.coli and A.aeolicus enzymes respectively. 
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growth between A.aeolicus protein purified by either method. As a consequence, the heat fractionation 
method was pursued, to allow faster and more efficient purification of the enzyme. This process yielded 
approximately 12mg/I protein of 95% purity as estimated by SDS PAGE. A typical preparation is 
summarised in table 3.1. 
5.2 Physical Characterisation 
5.2.1 Cofactor Binding 
It was observed that dissociation of the PLP cofactor from A. aeolicus AONS during chromatography and 
prolonged dialysis was minimal. Freezing of the enzyme was not observed to disrupt the enzyme-PLP 
complex and the protein solution also remained yellow on thawing. 
This contrasts to the behaviour of the E.coli enzyme, which loses most of its PLP during either freezing 
or dialysis. Initial observations of the UV/visible spectra of the AONS-PLP chromophore maxima 
indicated a wavelength of 430nm and it should be noted that this is slightly longer than the wavelength 
of 425nm displayed by the E.coli AONS chromophore. The absorbance coefficients of protein to internal 
cofactor aldimine complex were measured for both species of AONS by UV/visible spectrophotometry 
and they also show distinct differences. Measured 6(=425) for the native E.coli enzyme is 7,229 I mol' 
cm, while CQ430mfl) for the A.aeolicus enzyme is 11,317 1 mol' cm'. The higher value calculated for 
A. aeolicus AONS may indicate that there is increased cofactor binding for the PLP by the heat stable 
protein. However, the affmity of the proteins for their PLP cofactors could not be measured as size 
exclusion chromatography failed to separate the protein from the PLP molecule. Treatment of the enzyme 
with hydroxylamine reduced the amine bond and PLP could be removed. However, the enzyme was 
inactive. 
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5.2.2 Mass spectrometry 
The mass of the native protein, measured using gel filtration against known standards indicated that the 
protein was isolated as a dimer. 
Characterisation of A.aeolicus AONS by ES! mass spectrometry showed the monomer mass of the 
apoenzyme to be 42,306 Da (fig 5.2.1). This is 4 Daltons greater than the estimated value of 42,302 Da 
(PeptideMass (176)) and within the limits of experimental error. This mass indicates that the purified 
enzyme is post-translationally modified, with the loss of the N-terminal methionine. This modification is 
shared by E.coli AONS and occurred despite the artificial second residue introduced by the cloning 
procedure (see section 5.1). This characteristic has not been observed, however, by AONS purified from 
B.sphaericus (38). All three proteins have been over-expressed in E.coli host strains thus indicating that 
E.coli post-translational modification of A.aeolicus AONS occurs naturally and is not an artefact of the 
isolation procedure. 
The second, smaller peak is not readily identifiable, but could represent ions present from the purification 
buffer, such as potassium, within the protein. Alternatively, the additional mass of approximately 130 Da 
may represent a further amino acid, such as leucine or aspartic acid attached to the molecule. This may 






Mass spectrometry measurement of A.aeollcu.s AONS. The protein was separated from salts in the buffer by HPLC purification with H20/Acetonitrile containing 
0.01% Trifluoroacetic acid as eluent on a C5 column. The calculated mass of the protein, excluding the N-terminal methionine residue, was 42,302 Da. 
Data was refined using MaxEnt software. 
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5.3 Absorbance Spectra 
The UV-visible spectra of purified hyperthermostable A.aeolicus AONS can be seen to display peaks at 
332nm and 430nm. These are characteristic of the internal enzyme-cofactor aldimine for a PLP 
containing protein, indicating the presence of the ketimine, protonated at C 4 of the PLP, and aldimine 
respectively (130). On addition of L-alanine, the peak at 430nm becomes more defined and a strong band 
appears at 490nni. The 490nm absorbance maximum has been assigned to the first quinonoid 
intermediate in the reaction catalysed by AONS (36). However, this species is seen in the corresponding 
E.coii enzyme only upon addition of the second substrate, pimeloyl-CoA. The AONS quinonoid 
intermediate is very stable and decays slowly over a period of 12 hours at room temperature. 
L-alanine was titrated into the protein solution (fig 5.3. 1) and the dissociation constant for the substrate 
calculated by fitting the 490nm absorbance at each L-alanine concentration to a hyperbolic saturation 
curve in equation 2. A dissociation constant of 20jtM (±41iM) was calculated for the quinonoid (fig 
5.3.2). 
AArnax 
M [L - alanine] 
= ......................................................................Equation 2 
K + [L - alanine] 
This compares to a calculated dissociation constant for L-alanine in E. coil AONS of 900mM, suggesting 
a much greater efficiency of substrate binding is demonstrated in the A.aeolicus enzyme. On addition of 
L-alanine, the characteristic peaks at 332nm and 430nm can still be observed and do not increase 
significantly as the peak at 490nm increases, suggesting that the major species obtained on addition of L-
alanine is the quinonoid. 
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Figure 5.3.1 
Titration of 8iM AONS with 11.tM-1mM L-alanine. AONS was mixed with the substrate in 200mM potassium 
phosphate buffer, pH 7.5, and left to equilibrate for 30 minutes at 30°C. Acquisition of the spectra was at 30°C 
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Figure 5.3.2 
Saturation curve plotted by absorbance at 490nm vs L-atanine concentration. The dissociation constant 
was calculated using equation 1 above. 
P49C !V 
aftte 5: é aetc4atio 	 6dm ,14ez 4e0&a4 
In contrast, at higher temperatures, a peak at 490nm is not seen after incubation for 20 minutes with 
concentrations of L-alanine greater than 5iM. If left overnight, the incubated enzyme-substrate complex 
was seen to precipitate. No enzyme precipitation was observed, however, in the presence of L-alanine and 
the second substrate, pimeloyl-CoA. 
The spectrum of the enzyme-cofactor complex was investigated in different ionic conditions. There was 
no change observed in the spectra on addition of monovalent (Na*,  K. Cs) cations, or alteration of pH 
values in the range 6.5-8.5. The observed spectral changes on reaction of the protein with L-alanine 
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Figure 5.3.3 
Change in the cofactor absorption spectra of A.aeolicus AONS on addition of substrates and product. 
Spectra were acquired at 30°C and pH 7.53he PLP-AONS (5i.tM) spectrum is shown in black; in the 
presence of: 1mM L-alanine (blue); 1mM L-alanine and 10OM pimeloyl-CoA (green); 2mM AONS (red) 
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Formation of a substrate quinonoid, however, is inhibited by high concentrations (200mM) of divalent 
cations (Mg, Ca 2 ) as evinced from the absence of the 490nm peak. This inhibition is mimicked by 
E.coli AONS. In the absence of divalent cations, the peak at 490nm is greatly enhanced upon the 
addition of the second substrate. Under these conditions, a reduction in the absorbance of the peak at 
430nm can also be observed. Incubation of the AONS-PLP complex with the product AON at 30°C 
allows observation of an absorbance maximum at 51 Onm. This corresponds to the characteristic product 
quinonoid peak of the AONS-AON exhibited by the E.coli enzyme (36). 
5.4 Steady State Kinetics 
The coupled assay to measure kinetic activity uses the release of CoASH, a result of thioester cleavage by 
the Ca carbanion (see section 1.2.1). This is a substrate for the second reaction catalysed by a-
ketoglutarate decarboxylase, releasing NADH. The production of this molecule was followed by 
observing an increase at 340nm. The conversion of the observed velocity to concentration of pimeloyl-
CoA used up in the reaction was calculated using an absorbance extinction coefficient for NADH of 6300 
1 mol' cm'. 
Initially, temperature stability of AONS was measured by incubating the enzyme at a range of 
temperatures between 0°C-1 00°C prior to steady state assay at 30'C. This assay was carried out with 
excess substrate of 50mM L-alanine and 200 jiM pimeloyl-00A. The enzyme was active after prolonged 
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To establish the nature of therniostable activity, a single assay was carried out at defined temperatures in 
the range 0°C to 100°C using L-alanine and pimeloyl-CoA together with AONS present in 10mM 
potassium phosphate buffer, p1-I 7.5. The reaction was quenched after 10 minutes and coupled to the a-
ketoglutarate dehydrogenase reaction at 30°C. The resulting rate of reaction was plotted against the 
temperature (fig 5.4.1) and an increase in rate almost proportional to an increase in temperature was 
observed. This relationship was halted at 80°C, where maximum activity was observed and the rate of 
reaction subsequently dropped off as the temperature approached 100°C. 
0 	20 	40 	60 	80 	100 
Temperature (degrees celcius) 
Figure 5.4.1 
Temperature activity curve for A.aeobcus AONS. 21.iM AONS was incubated for ten minutes at 0°C, 20°C, 
40°C, 60°C, 80°C and 100°C in 10mM potassium phosphate buffer, pH 7.5, and 10mM L-alanine and 
100DM pimeloyl-00A. 50l of the quenched reaction was added to the components for the coupled assay 
to a volume of lml, and increase in absorbance at 340nm was recorded. The rate of pimeloyl-00A used 
in the reaction was plotted against temperature. 
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The temperature activity curve would suggest that the optimum activity for the enzyme lies at 
approximately 80°C. The drop off in activity as the temperature rises towards 100°C could be due to 
micro-precipitation of the protein solution. It may be that this does not correspond to the situation in 
vivo, where the protein may be stabilised by other cellular components. 
Table 5.2 
Steady state kinetic constants for AONS of A.aeolicus, E.coli, B.sphaericus. Steady-state kinetic constants 
for A.aeolicus AONS were measured at 30°C and pH 7.5 and fitted to equation 2 using Origin (Microcal) 
software. They are comparable to the values observed for E.coli and B.sphaencus AONS. The table is 
adapted with kind permission from Webster (36). 
pimeloyl-00A L-alanine 
AONS 	kat Km kat1Km Km k at/Km 
(sd ) (.tM) (s'M') (MM) (s'M) 
E. coli 	0.06(0.01) 25(2) 2400(430) 0.50(0.04) 120(21) 
A. aeolicus 	0.05(0.01) 15.5(1.4) 3226(645) 3.4 (0.3) 15(3) 
B. sphaericus * 	0.3 1.5 2x105 2.5 120 
$ B.sphaericus data was collected at 25°C by O.Ploux (39) (pers. commun. with Scott Webster) 
Steady state assays were conducted for the enzyme at 30°C and data was fitted to Michaelis-Menton 
saturation curves calculated by equation 1 (see section 2.4. 1) from which kinetic constants were obtained. 
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The low temperature was chosen to enable comparisons of the final constants with those of other a-
oxoamine synthases, in particular AONS from other species (Table 5.2). 
Both Michaelis constants for A.aeolicus AONS are similar to those of other a-oxoamine synthases, 
where the typical values are in the millimolar range for the amino acid substrate, and in the micromolar 
range for the acyl CoA (36) (38-39) (45) (177). 
The largest differences in the constants calculated from each AONS species is observed for the 
B.sphaericus enzyme. This assay was performed independently by Marquet's group in France and did not 
use a coupled assay, relying instead on measurement of an absorbance decrease at 230nm, indicating 
cleavage of the pimeloyl-00A thioester bond. The assays were also conducted at 25°C. For these reasons, 
although the relative concentration ranges of the constants for each substrate are similar, it is not known 
whether the larger discrepancies, particularly in the turnover number, could be attributed to differences 
in the activity of the enzyme, or in the assay method. Attempts to duplicate their assay proved 
unsuccessful for measurement of E.coli (36) and A.aeolicus AONS kinetics. 
The k of the A.aeolicus AONS reaction is 0.05 sec' at 30°C. This is similar to the E.coli enzyme and 
would indicate a similar rate of turnover. The A.aeolicus enzyme, however, functions best at 
temperatures of 80°C and it would thus seem obvious that the kinetic constants at higher temperature 
would be consistent with an elevated rate of reaction. Steady state kinetics were therefore also carried out 
at 60°C and 80°C in the form of a quenched assay (Table 5.3). 
The increase in temperature manifests itself as a 25-fold increase in turnover of the A.aeolicus AONS 
enzyme at 80°C in comparison with its catalysis rate at 30°C. An activation energy for the protein can be 
calculated using equation 4, and E 0 = 53 kJ mold . This corresponds to the activation energy of 
50 Id mol' seen over a 10°C - 40°C temperature range for mesophilic proteins (178). 
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k 2 	Ea T2 —T 1 
log— = ( 	) 	 .Equation 4 
k1 2.3R T2 TI 
Table 5.3 
Steady state kinetic constants for AONS of A.aeolicus, at 60°C and 80°C 
pimeloyl-00A L-alanine 
Assay 	kcat Km 	 kat/Km Km 	"cat/Km 
temperature 	(sd ) QiM) 	(s1M) (tM) 	(s1 1W) 
60°C 	0.45 (0.02) 18(1) 	25,000 (1125) 203 (34) 	2,217 (277) 
80°C 	1.25 (0.1) 22 (3) 	56,818 (6136) 52 (19) 	24,000 (636) 
There is very little difference in the apparent K m values for the second substrate, pimeloyl-CoA across all 
three temperatures, although the specificity of the enzyme for this substrate does increase, as evinced by 
the LJKm  values. There is, however, a visible reduction in the Km for L-alanine on elevation of 
temperature, such that the constant value at 80°C decreases 65 fold on the value observed at 30°C. The 
binding specificity of A.aeolicus AONS for L-alanine rises significantly with each increase in 
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Plot of log kcat versus l/T for A.aeo!icus AONS at fixed temperatures of 30°C, 60°C and 80°C. Turnover 
was measured using the quenched assay. 
5,5 Sequence alignment 
There are currently 12 fully annotated AONS sequences in the SwissProt database (23) (26) (31) (33) 
(179-185) together with 5 translated sequences in TrEMBL (186-189). Sequences of AONS from a 
further three species can be found at (lenbank (190-192). Of these sequences, 18 are independent. Only 
one of the sequences represents AONS from an archae bacterium (see section 1.2.2), Meihanococcus 
jannaschii. 
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Residues already recorded as being essential for cofactor and substrate binding in PLP dependent 
enzymes are strictly conserved. However, two specific active site residues in E.coli, glutamate 175 and 
tyrosine 264, a residue contributing to the active site from the opposite monomer, are not always 
conserved. They may become aspartate and phenylalanine respectively in several species, although there 
is not necessarily a correlation between either residue to suggest that they are present together in the 
active site. Exceptions to this change are the AONS proteins of Chiamydia sp. Chiamydia trachiomatis 
has a leucine residue in the position where a tyrosine or phenylalanine is usually found, and Chiamydia 
pneumoniae (bioF 1) has a serine residue instead of the more usual aspartate or glutamate residue. The 
initial glutamate/tyrosine combination can be found in the active site of E.coli AONS, whilst these 
residues are replaced by aspartate and phenylalanine in the A.aeolicus and B.sphaericus proteins. Two 
asparagine residues found in the active site of the E. coil protein (N47; N112) are conserved in all 
species. It is already accepted that asparagine is one of the residues generally replaced by a polar residue 
in heat stable enzymes. Thus this conservation suggest that both residues are vital for enzyme function. 
A.aeoiicus AONS displays other differences in its sequence compared with the E.coii sequence. The 
initial N-terminal a-helix seen in E.coli seems to be smaller in its thermophilic counterpart, although 
residues towards the C-terminal end of the protein show a high degree of conservation. The sequence of 
the hyperthermophilic enzyme also displays an increased percentage of ionic residues - in particular 
lysine and glutamic acid residues, and a distinct reduction in the number of alanine and glutamine 
residues. One third of the A.aeoiicus gene is composed of charged residues. This compares to 20% for 
the E.coli and 27% for the B.sphaericus enzymes. The A.aeolicus enzyme sequence is closer to the 
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(209) AV V QNCLIAERAVIAD-1DLLVG 
(194) I ENLLFLEYYRIKEKDKIIKL 
(196) G 	C D-3 	LKHF:I:KPSDNIVQIG 
(205) GL R C_C LVYEV'ThAGAPDVVI 
GL R, -G 	LYEL LAGAPDVV11 
(209) AX YI;QNGL IAERD';CIAE-CDLLVG 
(205) G PL;ASGG IVEHF::GQEQVPVLIG 
>207) GI '':REQG SCWQQCVRPE---LLVA 
(258) G 	MHKMTCREHFQ:PVG-DWIQVG 
If f' 
V F CGTKLLIDY V K CL F 
V GY GAKP IEY L H CL FT 
I AK GE S :SI K 'fL N S F 
V AK GE G AV IDF L H T F 
A N CII FRYE F I K A V 
TM SLL SEVKYD MQNSPPLPY 
'ITH Al G CLLKDY I F P YT 
I A AWL PDRK D I -EPMVC 
C,G VS A L EAVATY EQF HL Y 
G VS A L STVADY LQF HL V 
A N V V QILKEC I QM PL F 
AX CILA LQ lET R'KSV VT 
I L GE CGIEEVVEY'I rs C F 
QGALGSAVRA I.T P F 
O GV LG TPVRA I A) P F 
AV Y 	QVLKEC IQMPL F 
C TA F C EELIET 1QY 7 , 1 NY YT 
VS AL FA AEYLQF: HL V 
L GY G ASLIDF R P ATM YT 
,.J.g 
S 	SCAGARK IEIIE--ENPKLIEF 
V IVASHLA LQIVQ--EQPWREK 
SAlE AREGISIIQ--NEFERRKQ 
I ASCA ARE NIIE--ASREKFQL 
INVAWTQF,I KKMP--YFKKEREK 
S HTLISIGT YDI'LA-SEGEIARKQ 
0 HAL IEL'YEHNQ--RAFNQREH 
GI ILL SIQV'YE LS-QEGELARTR 
SM AQ LSA LSVIRGEEGDQRRTA 
SM AC Q LRASLAVIRSDEGDARNEK 
ENVAWTI-IFI ERLP--QLSKEPTH 
LCD ALTLAHLEYCI ---- VQK)EL 
HVVEGCIR EZE --- KTDIVKK 
C AAAVG ARA LQILK--AETW-RP-
G A AAVG ARA LRVQ--AEPW-RP- 
FNVAWTYFI ERLP--QFSKERSH 
SQ AV TLKSLELLR--RESWRRQH 
11 AC ;LQA:LARXR--EGDDLPAR 
G AD r,ALA:IQtIQ__REpERIVQ 
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Aquifex aeolicus (280 RKF'FTFIJ ELLEQr---SLDYKYYSTPI IMVYDEEE IKE VFI. 	K KA 	LTASiJYTi 	D1,EV !`NA K 
Bacillus halodurans (297) V ,,-., V T! 	NGLEQL --- GFSZCGSESY.V VU DNHLi VS: 	QAA IA IV RE 	I LTVT zAMiT ;n;ç 
Bacillus sphaericus (294) LEN Q?L LKLEES --- GFVMKEGETPI LII SHE MQ SK LDE VFIP 	K SS ITVN THTIE L MVISKIK 
Bacillus subtilis  LFSYISMIiTSLKNM --- GYVVKGDHTP I VVI DAHK VL ••EKIQGK IYP APES I ITITSDMSMGDI H LQT H 
Campylobacter jejuni (296) LEL:,STFFRSKLQEK --- NHIVLG-D Y. ICLLL ENKK EISQK QKA 	F P 	KE 	(K::TA, I 	S K GL TEELERIIEL - 
Chiamydia pneumoniae (BioFi) (270) VFKKEHF ECD ------ SHPG --- CVQ I LP TC-LEE ISV ETTI 	G VAFA H ---- F. 	V 	HY TVDEV L 	QVMK 
Chiamydia pneumoniae (B1oF2) (284) :SAIHHFkEK QNLG-LQLMKDNTTTP:Q ICy SHRRQ LQIQNS Y0:RP:V 	KQRE L .I 	H F TENEI HLHT E 
Chiamydia trachosnatis (270) :RRIRDYFAQKIS ------ WA:.AG --- KVQ LSLP IS-EQELYQK:VATIRG ACEPTGK---V H FTEQEV IVSLA 
Erwina herbicola  LAGIQRFHG AAL --- PGRITHSQSATQ LIV DNSR:.:SERiRQKCW T. , PPTVPA;Tk..:LT TALPEDI RLEVLH 
Escherichia coil (295) r..AA:1TRFAGVQDL---PFTLADSCSA:Q LIV DNSRQLrEK:RQQCC$T..RPPTVEATA LT T All MQDIRLEV:H 
Haemophillus influenzae (296) LEQ.SAFLQEVEHR --- TQIMPS-QTCV YIL ENEA :AK:KD:QEQ.;YCLPIRPPT':K TS I LS T DMTADEV Q 	VH;- 
Helicobacter pylon (280) KNE:SKHQ;II ETLG--IRTLAG---- 	LE K NPAL:NHHF: EKE 	GAIRPPTV --K L 	VS SLE SLED 	E 	NTLL 
Methanococcus jannaschii (282) IQKNIKIA KV KKY --- EFIKEDNLTP Y 	I KEKT--MEtEH: lEN IFCVGTRYPTVI K L 	I VSI 	GH KED EL CERK 
Mycobacterium leprae (290) -EAVI1QHATL:KIC --- DLSELP-QSAVV VVL DPEV::A IACLDA :VR:G 	•iLPTVPA4T8 LTAH EL SA LEVARRVLT 
Mycobacterium tuberculosis (294) _QAVLNHAGELRMC --- GVA:VP_DSAMV VIL EPESLVA:J.AACLDAVK:G!KPPTVPA,:TS  LTAR EL AGELELARRVIT 
Neissenia menningtidis (296) LEQLSAFLREVAHR --- TQIMPS-QTC V YIL NEA!LAKAEYLQRQYYCLPIRPPTVPK'TS I LS T PMTMDEV Q 	AC:- 
Pseudomonas aeruqinosa (293) LAALIARFHG.EAL---GLTLMDSFTP.Q ILV SRQVALJGMIRARTGRPPTVPASA VT S ARSEA V R LEA:G 
Serratia marcescens (292) :QDNIRRF QG .APL --- ALTLTDSDTAQ LLV DNQR 'DL :.TR:RECLW SLPTVPP:GA 	LL T AHSQDI RLEV:N 
Synechocystis PCC 6803 345) QLNVDYLATGLESLTKLNFRRSPINSP LWVG A PAM EM :KH REQ IF p: 	 --HS I 	SVM THSPG I Q LEV D 
Figure 5.5.1 
Sequence alignment of the twenty known sequences of 8-amino-7- Aqufex aeolicus (367) KVLKGRA------------------------- 
Bacillus halodurans (384) RLPLVGRRELTP-------------------- 
Bacillus sphaericua  KIGKEMGIV ----------------------- oxononanoate synthase. The conserved residues are shaded red and 
Bacillus subtilis (381) SIGKELHII----------------------- 
Campylobacter jejuni  -------------------------------- similar residues are boxed in grey. Blue denotes identity over at least 12 
Chlawydia pneumoniae )BioFl) (346) PYLEKSSHRVHINHEFHLWRELCQH------- 
Chlamydia pneumoniae (BioF2) (373) QIFLCNVSSL---------------------- sequences. The secondary structure of the E.cali enzyme is overlaid across 
Chlamydia trachomatis (346) TEQVTYQKNVVTGSTSTMQRTLEDNFAAANAS 
2lrwina herbicola  ESGE ---------------------------- thetopofthesequence, identifying residues involved in u-helixand 3-sheet 
Escherichia coli (382) GNG----------------------------- 
Haemophillus influenzae () ::::::::::_::_::i: formation. Sequencing was carried out using Clustal W on the EBI server. Helicobacter pylori (362) NYSKIQSSFKSG 
Methanococcus jannaschii (367) EVYSSD-------------------------- 
The default blosum matrix was chosen. The sequences were formatted Mycobacterium leprae (375) DVLGGCCVARR--------------------- 
Mycobacterium tuberculosis  DVLA --- VARR --------------------- 
Neisseria menningtidis (381) -------------------------------- using ESPript (www-pgm1.ipbs.fr:80801ESPript). The accession numbers 
Pseudomonas aeruginosa  ESWRQLSSSLLAEIEAEEGDDA---------- 
Serratia marcescens (379) DVSQ---------------------------- of all sequences from top to bottom are: 025320; Q9ZLN3; P44422; 
Synechocystis PCC 6803 (433) HYYPN --------------------------- 
NC002203; 	Q9PIJ3; 	P22806; 	P53556; 	058694; 	066875; 	P74770; 
P12998; 047829; P38570; NC002516; P45487; 006621; NC002570; 
084782; Q9Z6Y3; Q9Z6L 
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5.6 Mutagenesis of A.aeolicus AONS 
The conserved histidine residue, found to lie in parallel with the pyridine ring of the cofactor was 
mutated in E. coil AONS to a phenylalanine residue, resulting in reversible loss of cofactor binding. It 
has already been observed that PLP binding in A. aeolicus AONS is greater than in the E. coil enzyme, 
thus the corresponding mutation (Hl 18F) was created in the heat stable protein to investigate this 
observation. Mutagenesis was carried out using the megaprimer method as for the E.coli mutants (see 
section 2.3.5) and the mutated gene cloned into pUCI8 at the NcoIIBamFll sites. It was subsequently sub-
cloned, using the same digest, into the pET 16b over-expression plasmid. 
5.7 Isolation and purification of HII8F 
Over-expression and purification of Hl 18F was carried out according to the protocol developed for wild 
type A.aeoiicus AONS. The mutant protein eluted from the anion exchange column at 140mM NaCl. 
The yield of 10mg/I was similar to that obtained for the wild type enzyme, and purity was >95% as 
judged by SDS PAGE of protein with specific activity 0.1 U. A small amount of PLP cofactor remained 
bound to the mutant protein throughout the purification and freezing process, suggesting that, unlike its 
mesophilic counterpart, the PLP binding within the active site is not totally lost. 
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Table 5.4 
Purification table of A.aeolicus Hi 18F/AONS from expression in an E.coli host. Protein concentration was 
measured using the method of Bradford and specific activity was measured in a coupled assay using 
50mM L-alanine and 200PM pimeloyl-00A. 1U AONS represents the transformation of ij.tmol pimeloyl-
CoA by 1 m enzyme per minute at 30°C 
Purification Step Volume 	Protein 	Specific 	Total 	Yield 	Purification 
(ml) 	(mg/ml) 	activity 	activity 	(%) 	fold 
(U/mg) 	(U) 
Crude extract 41 16.4 	 -- 	 -- 	 -- 	 -- 
60°C fraction 36 10 	0.007 	2.52 	100 	1 
80°C fraction 32 8.6 	0.009 	2.47 	98 	1.3 
Anion exchange 20 1.1 	0.1 	2.2 	88 	14 
5.8 Physical Characterisation of HII8F 
Dialysis against potassium phosphate buffer, containing I 00.tM PLP followed by exhaustive washing 
showed that PLP remained bound within the enzyme. The measured coefficient for cofactor binding at 
395nm is c=1673 I mol' cm. This is a seven-fold reduction from the chromophore binding observed in 
the wild type enzyme (see section 5.2), and the shorter wavelength would suggest that the orientation of 
the imine bond of the internal aldimine within the active site has been altered. The fact that the total PLP 
did not disappear after exhaustive washing indicates that the cofactor is actually held within the active 
site. 
An approximate size was estimated for the mutant proteins by SDS PAGE analysis, using wild type 
AONS as a reference and was necessary during the purification process. As expected, the mutant protein 
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band ran concurrent with the wild type band. The predicted mass of the HI 18F mutant enzyme has been 
identified by ESI mass spectrometry. The predicted mass of the protein is 42,542.16 Da and the 
calculated mass 42,544 Da. 
5.9 UV/visible Characterisation of HII8F 
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Figure 5.9.1 
Change in the cofactor absorption spectra of A.aeolicus AONS for wild type and mutant protein. Spectra 
were acquired at 30°C and pH 7.5. Hi 1 BF/AONS holoenzyme (black); in the presence of 50mM L-alanine 
(red); wild type AONS holoenzyme (green). 
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These are defined as the protonated and non-protonated forms of the internal aldimine respectively. The 
shorter wavelengths indicate that the normal orientation of the cofactor is perturbed. On addition of the 
first substrate, L-alanine, no quinonoid peak is observed. There is also no increase in the wavelength at 
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Figure 5.9.2 
Titration of 81.tM Hi 1 8F/AONS with 1 .iM-i m  L-alanine. AONS was mixed with the substrate in 200m  
potassium phosphate buffer, pH 7.5, and left to equilibrate for 30 minutes at 30°C. Acquisition of the 
spectra was at 30°C and pH 7.5. Concentrations are: 1mM (black); 10mM (red); 20mM (green); 50mM 
(blue). 
The kinetic activity is evidence that the reaction proceeds, so a lack of visible quinonoid would suggest 
active site dynamics created by the mutant which do not favour the stability of this intermediate. 
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Although the absorbance maximum of the internal aldimine is shorter than wild type, it remained 
distinguishable from the absorbance peak of the free PLP molecule at 390nm. The wavelength for the 
aldimine peak increases on addition of L-alanine, but remains shorter than the wavelength assigned to 
the enzyme-cofactor aldimine of the wild type protein. 
The mutant protein was titrated with increasing L-alanine concentrations and a slow shift in wavelength 
could be observed as the concentration increased. An isosbestic point is indicated at 330nm, suggesting 
equilibrium between the protonated and unprotonated species. 
5.10 Steady state kinetics on HII8F/AONS 
The steady state kinetic parameters for the mutant enzyme were calculated using constants obtained from 
the activity of the protein in the coupled assay at 3 0°C, pH 7.5 (table 5.5). 
Table 5.5 
Steady state kinetic constants for AONS of A.aeollcus, wild type and Hi 18F mutant. Steady-state kinetic 
constants for each substrate were measured at 30°C, pH 7.5 in the presence of the other substrate and 
data fitted to Michaelis-Menton saturation curves. Protein concentration used in the assay was ijtM. 
pimeloyl-CoA 	 L-alanine 
AONS 	 kcat 	 Km 	kcat/Km 	Km 	kat/Km 
(s) 	(j.tIVI) 	(svr') 	(miVi)  
Wild type 
	
0.05(0.01) 	15.5(1.4) 3226(645) 	3.4 (0.3) 	15(3) 
H118F 	0.006 (0.0005) 	55 (7) 	109 (21) 	8.2 (2.6) 	0.7 (0.1) 
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The results suggest that the phenylalanine mutation reduces the turnover rate of the reaction to Ca. 10% 
of the wild type activity. The binding efficiency of both substrates is also reduced, and this, together with 
the changes in kmax of the aldimine indicate a possible incorrect orientation for the pyridine ring of the 
cofactor within the active site. 
There is a twenty-fold reduction in formation of the external aldimine and consequently the reaction of 
the amino acid substrate with pimeloyl-CoA is lowered to almost thirty-fold below the wild type activity, 
suggesting that once L-alanine is bound, the reaction with pimeloyl-CoA proceeds at Ca. 10% wild type 
rate. 
5.11 Crystallisation of A.aeolicus AONS 
Protein fractions containing 95% pure AONS were pooled and loaded onto a Superdex 75 gel filtration 
column for buffer exchange from 20mM potassium phosphate, pH 7.5 to 10mM bis-tris propane, pH 7.5. 
This exchange was originally carried out in order to reproduce the conditions which led to the 
crystallisation of E. coli AONS (37). Subsequent light scattering experiments carried out on A. aeolicus 
AONS indcated that a low salt buffer such as bis-tris propane was necessary to reduce aggregation of the 
protein, thus confirming the choice of buffer. A further indicator was the crystallisation itself. As a 
control, crystal trials were conducted with 20mM potassium phosphate buffer, pH 7.5 but, as expected, 
the buffer contributed to aggregation of the protein and a solid precipitate formed throughout the droplet. 
Initial crystal trials were conducted at varying pH values with ammonium sulphate as the precipitant; 
emulating the conditions under which the E.coli AONS crystals were produced. These trials were 
conducted in Linbro® 24 multi-well plates in the hanging drop version of the vapour diffusion 
technique. Initial trials with commercial Structure Screens I and II were also set up as sitting droplets 
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within the well solution. Protein set in trials containing polyethylene glycol (PEG) did not form crystals 
at any concentration of either protein or PEG. 
Crystals were only produced in those drops containing unbuffered (N}1 1)2SO4 at pH 5.5. Further trials 
were set up to define the optimum protein and precipitant concentration. The protein solution was 
concentrated to 10mg/mi and crystallised just as well between 1.6M-2.5M (NH 4)2 SO4 
Yellow trapezial crystals were produced and crystals grew at temperatures of 17°C, 37°C and 60°C. 
Coloration was due to the presence of the PLP cofactor which was not lost during either the 
crystallisation or the freezing process. This contrasts to the behaviour of the E.coli protein, which loses 
its cofactor under these conditions. Growth was slower at the lower temperatures and at 17°C it took 14 
days for crystals to reach an average size of 0.5mm x 0.2mm. Much of the protein had aggregated and 
many crystals grew through a layer of precipitate in the droplet. Such aggregation would suggest a 
protein concentration higher than necessary, but reducing this concentration resulted in no crystal 
formation at all. At the slightly higher temperature of 37°C, crystal growth was slower and the average 
crystal size after 4 weeks was 0.3mm x 0.2mm x 0.2mm. Crystals grew at concentrations between 0.5M-
0.7M (NH4)2SO4 and there was no precipitate observed in these wells. At 60°C, crystals grew under the 
same precipitant conditions observed at 17°C and attained the same average size after only 7 days. 
All crystals were grown by the vapour diffusion method and trials at 17°C were conducted using the 
hanging drop technique. The sitting drop version was employed for trials at 37°C and 60°C, as this 
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Crystals were mounted on cryoloops and frozen in liquid nitrogen after protecting them from freezing 
damage with Paraton N oil. This was found to preserve the crystals, which dissolved slowly on contact 
with a more traditional cryoprotectant made by addition of glycerol to the mother liquor. 
Figure 5.11.1 
Crystal grown at 60°C. Rhombic crystals were grown by the sitting drop method and achieved a 
maximum size of 0.5mm x 0.2mm within 7 days. 
5.12 Data Collection 
An initial study of the viability of a crystal for X-ray diffiaction was conducted at the Structural Biology 
on-site facility in Edinburgh. Data was collected over an exposure time of 30 minutes at 100K using a 
MAR research 345mm image plate at a distance of 300mm from the crystal. Most of the crystals were 
twinned, but a single crystal grown at 60°C diffracted to a maximum resolution of 4.6A and was taken 
forward to SRS CLRC Daresbury Laboratory, Warrington, UK for data collection. 
X-ray diffraction data was collected at station 7.2 at lOOK using a MAR research 345mm image plate at 
a crystal-to-detector distance of 300mm for 181.6° at an oscillation angle of 0.8°. The wavelength was 
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= 1.488A. High resolution data was collected over an 18 hour period in the range 20A-2.94A. The 
image plate was set at a distance of 300mm. A second pass of 180° with an oscillation angle of 30  and 
detector set at 500mm provided low resolution data between 30A4.6A. Data was processed and scaled 
using DENZO/SCALEPACK software (124). 
Crystallographic data was consistent with the space group; P2 1 2 1 2. The unit cell was relatively large with 
dimensions of a = 159.93, b = 188.16, c = 95.13 and unit angles a=1=y=90°. 
Table 5.7 
Crystal diffraction parameters. Data was collected in two passes, reflecting high and low resolution data 
sets. These were processed and scaled using DENZO/SCALEPACK. Values in parentheses are for the 
high resolution shell 3.36A-2.94A 
AONS holoenzyme 
Space group 	 p2 1 2 1 2 
Unit cell dimensions (A) 	 a = 159.93, b = 188.16, c = 95.13 
Unit cell volume (A3) 	 2.8 x 106 
Completeness (%) 	 99.6 (98.8) 
I> 3cy(I) (%) 	 32.8 (66.2) 
Rmerg ,(%) 	 11.1 (49.9) 
Unique reflections 	 55,562 
Multiplicity 	 7.9 (6.0) 
The space group indicates a primitive lattice arrangement, indicating that there is one lattice point per 



















Space group P212 1 2. The origin is in the plane of the paper, and black shaded areas indicate the two-fold 
dyad axis parallel to the c axis through the plane of the paper. O indicates a molecule above the plane of 
the paper, and 0 indicates one below this plane. The half arrows represent the positions of the two-fold 
screw axes. 
The space group also displays perpendicular screw axes parallel to a and b and a single two-fold rotation 
axis parallel to the c axis. This space group also indicates the relationship between the four asymmetric 
units located within the cell: x,y,z; 1/2 + x, V2  + y, -z; '/2 - x, '/2 + y, z; -x, -y, z. Any atom is present in four 
copies at each of these positions in the cell. 
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5.13 Data Resolution 
The temperature factor of the data was elevated, at 60.2A 2 , as estimated from the Wilson Plot 
Patterson maps were calculated using diffraction data in the resolution range 30A-2.94A. A large 
translation peak was observed at fractional co-ordinates of 0.243 x 0.500 x 0.500, the height of which 
was one third of an arbitrary origin. The co-ordinates of the translation peak define the non-
crystallographic translational symmetry operators, which will be used to find the arrangement of 
molecules within the unit cell. 
The phase problem was much simplified as the structure of E.coli AONS had already been solved (37), 
and can be used as a model for the molecular replacement method (126). The crystallographic were space 
group P2 1 2 1 2 was confirmed by molecular replacement, which was most successful using this space 
group. 
Due to the large volume of the unit cell, there was some doubt over the number of protein molecules 
within the asymmetric unit of the cell. The E.coli enzyme exists as a dimer, and gel filtration studies 
have indicated that the same is true for the A.aeolicus enzyme (see section 5.2). The Matthew's 
coefficient (Vm) can be calculated using equation 3 and defines the crystal volume per unit of protein 
molecular weight (193). 
V 
Vm = . ...............................................................................Equation 3 
M.Z 
where V(A3) is cell volume; M (Da) is relative molecular weight; Z is the number of molecules in the 
unit cell 
Pate 123 







Patterson Map. The map was calculated using the CCP4 suite of programs and shows a single large 
translation peak at 0.2434.5004.500. 
The CCP4 program Matthews was used to calculate Matthews' coefficients. The mass of each subunit is 
42,306 Da (see section 3.2) and a P2 1 2 1 2 space group allows four possible asymmetric units within the 
unit cell (see section 5.12). Thus Vm = 8.27 A3Da' for one dimer and 2.76 A3Da' for three dimers, or 
six subunits. The most commonly observed coefficient is approximately 2.15 A 3Da' (193), thus up to 
fours dimers in the asymmetric unit would not be impossible. 
a12 
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Using the AONS structure from E.coli as the molecular replacement model, the dimer did not produce an 
interpretable rotation function. With the monomer, however, the two best solutions showed the 
monomeric protein arranged in a dimeric conformation similar to that already established for the E.coli 
enzyme. This dimer was used as the new search model for molecular replacement and two further dimers 
were identified. 
AONS from B.sphaericus5 has a higher sequence identity to A.aeolicus AONS (see section 5.5) and 
molecular replacement studies were repeated using the B.sphaericus dimer rather than the E.coli 
monomer as the model (table 5.8). This not only confirmed the solutions previously identified with 
E.coli, but provided a significant improvement of the molecular replacement solutions found. 
Three RI peaks were superior to the subsequent solutions, which displayed RI values of 4.54cr and below. 
Each rotation function solution was used to search for an appropriate translation function, which would 
specify the location of the dimer in the asymmetric unit. As each dimer was added to the model, the 
correlation factor increased to a final value of 0.362 for the six subunit solution with an R factor of 
52.6% (Table 5.9). 
Table 5.8 
Molecular Replacement solutions for A.aeollcus AONS. The B.sphaencus AONS dimer was used as the 
model molecule. 
Solution a (alpha) 	(beta) 	y (gamma) 	0 (theta) 4) (phi) x (chi) 	RI 	RI/cr (sigma) 
71.32 	74.53 	47.07 	41.53 	102.12 	131.9 	0.4072E 5 	13.36 
2 	83.78 	44.41 	137.8 
3 	165.16 	27.2 	147.71 
	
156.41 	-117.01 	141.63 	0.2144E 5 
28.52 	-131.27 	59.01 	0.2122E 5 
7.04 
6.96 
The co-ordinates for this macromolecule were communicated to D. Alexeev from C. Cambillau, France 
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The NCS dyad axis relating the two monomers of the dinieric molecular replacement model is parallel to 
y for the first Rf solution. This gives a translation function peak consistent with the observed translation 
function peak in the Patterson map. 
Table 5.9 
Translation search for each of the three rotation function solutions. These were calculated using the three 
dimeric rotation functions. R factors and correlation coefficients are the result of a cumulative effect for all 
subunits. 
Rotation a (alpha) 3 (beta) y (gamma) xfrac yfrac zfrac R factor Correlation 
solution 
1 71.32 74.53 47.07 0.412 0.472 0.088 0.565 0.295 
2 83.78 44.41 137.8 0.238 0.978 0.426 0.538 0.302 
3 165.16 27.2 241.71 0.670 0.066 0.422 0.526 0.362 
The dimer clustering observed in the graphical representation of the unit cell suggested room for a fourth 
dimer within the asymmetric unit, although there was no molecular replacement solution to reinforce this 
observation. 
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5.14 Structure Refinement 
Based on the sequence alignment of A.aeolicus and B.sphaericus AONS, the amino acid residues of the 
latter were replaced with those of the heat stable protein. The resulting model was displayed over the 
average electron density map, which was calculated using CNS suite of programs (128) and averaged 
using the CCP4 suite of programs. All graphical data was viewed in 0 on a Silicon Graphics 
workstation. 
Figure 5.14.1 
Probable unit cell make-up using dimenc B.sphaericus AONS molecules fitted to the A.aeo!icus AONS X-
ray data. Clustering of the subunits suggests room for a fourth dimer. The diagram was created in 0. 
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The molecular model was manipulated to fit the electron density maps 2F,,-F. and F 0-F, and the maps 
recalculated. The initial refinement factor (R factor) of the data to the electron density maps was 52%. 
Manual adjustment of the residues in the map was carried out many times, but the R factor did not go 
below 49%, suggesting a possible error in the initial data. As the majority of crystals tested were 
twinned, and the spot pattern from the processed data set far from perfect, it is possible that the quality of 
this crystal was not good enough for structural studies. Further refinement of this data is thus now 
beyond the realms of this project. 
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Discussion 
Over-expression of the hyperthermostable protein in a functional form was achieved in E.coli at 37°C, 
indicating that a high temperature is not required for correct folding of the enzyme. Post-translational 
modification of A.aeolicus AONS, in the form of loss of the N-terminal methionine, was also observed, 
despite the presence of a mutated second residue. Correct folding of the enzyme at temperatures well 
below its native surroundings suggest that the conformational fold of the protein is stable over a wide 
temperature range. Other recombinant proteins of a thermophilic origin expressed in a mesophilic host 
generally have the same properties as their mesophilic counterparts, indicating that thennostability is an 
intrinsic property (140). A.aeolicus AONS becomes unstable, however, when purification takes place at 
4°C. This is consistent with observations by Jaenicke and Böhm (152) on refolding of the heat stable 
protein, glyceraldehyde 3-phosphate dehydrodgenase (GAPDFI). This enzyme folded incorrectly at 
temperatures below 10°C. Conclusions as to why this might be the case are, as yet, unclear, but the 
inefficient packing of hydrophobic core may form part of the cause. Hydrophobic packing is prevalent in 
hyperthermophilic globular proteins (162), in particular those with an optimum activity below 100°C 
(160) (161). It has been suggested (165) that hydrophobic interactions may become weaker below room 
temperature and specific hydrophobic states, which may be critical for subunit assembly of the dinier are 
not attained (194). 
Initial kinetic studies of A.aeolicu.s AONS suggest that the catalytic mechanism for this 
hyperthermostable enzyme is similar to the E.coli enzyme, which has been suggested to follow an 
ordered bi bi pathway (36) (178). The hyperthermostable protein is active both at low and also very high 
temperatures, indicating a flexible active site. Activity at 30°C is comparable to the mesophilic E.coli 
and B.sphaericus enzymes, an observation consistent with the activity of thermophilic aspartate 
aminotransferase from Thermus thermophilus (195) which displays a similar activity at lower 
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temperatures to its mesophilic counterpart. As activity is seen to increase at higher temperatures, this 
kinetic observation would suggest that catalysis is less than optimal at 30°C, and indeed, a higher 
turnover is observed at temperatures up to 80°C. Activity was observed to decrease slowly between 80°C 
and 100°C, possible due to microprecipitation of the protein. This observation is consistent with enzyme 
activity within a bacterium surviving at 89°C and is comparable to other heat stable enzymes studied 
(161) (174) (196). Assays at 60°C and 80°C indicate that specificity of the enzyme for L-alanine is 
enhanced at elevated temperatures, suggesting a conformational change in the protein may occur. 
Although the turnover of A.aeolicus AONS approximates that of the E.coli enzyme at 30°C, both 
proteins are active at one fifth of the rate reported for the B.sphaericus enzyme. It should be noted here, 
however, that the assay methods were different. Sequencing has shown that the majority of active site 
residues are conserved throughout all AONS sequences, but it is possible that the aspartate/phenylalanine 
couple in both A.aeolicus and B.sphaericus enzymes has an influence on the rate of reaction, and thus 
the turnover. 
On addition of the first substrate of the reaction, L-alanine, an intermediate is observed with a 
wavelength at 490nm. This has been assigned to the formation of the first reaction quinonoid and is seen 
in E.coli AONS only after addition of the second substrate, pimeloyl-CoA (36). The quinonoid is the 
result of abstraction of the C 2 proton (197) (39) and modelling has suggested this intermediate may be 
stabilised by a strictly conserved active site asparagine (N47 in E.coli AONS). In the E.coli enzyme, 
Webster et al (36) demonstrate that there is a time lag on addition of pimeloyl-CoA and suggest that it is 
necessary to confer a rotation about the Ca-N bond in order to place the C 2 proton closer to the critical 
PLP binding lysine, allowing proton abstraction by the base and thus the quinonoid is not seen on 
addition of L-alanine alone. Ploux eta! (39) also suggest that the presence of both substrates is necessary 
to optimise heterolytic cleavage of the C 2-H bond, as rupturing of this bond is slow. However, a 
stereospecific exchange of the C 2 proton by an active site base has also been observed in the B.sphaericus 
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enzyme in the absence of pimeloyl-CoA. This may suggest that proton abstraction occurs as a result of 
binding of the amino acid substrate, but the formation of the quinonoid intermediate proceeds too fast in 
E.coli to allow the quinonoid to be visible by UV/visible spectroscopy. The lag that is observed in this 
enzyme upon pimeloyl-CoA binding may be as a result of the conformational shift around the C,,-COO -
bond, placing it orthogonal to the pyridine ring of the cofactor ready for decarboxylation. Thus it may be 
postulated that slowing the reaction of L-alanine with the cofactor by incubation of the heat stable 
A.aeolicus enzyme at 30°C allows observation of the quinonoid. This phenomenon is also seen in the 
ALAS enzyme of Rhodobacter sphaeroides (49) in the form of a peak at 51 Onm, which is observed on 
addition of glycine. Analogous to A.aeolicus AONS, the peak is enhanced on titration of the amino acid 
substrate. This peak has, however, not been observed in the erythroid form of ALAS (50) (177), which 
has been well characterised. Comparison of the protein sequence of the Ksphaeroides enzyme (198) with 
that of mouse erythroid ALAS (SwissProt accession number: P08680) and the AONS enzymes of 
A.aeolicu.s and E.coli suggest no obvious change in the active site that would enhance quinonoid 
formation to a degree that it is visible by UV/visible spectroscopy. Measurement of the equilibrium 
dissociation constant for L-alanine in the micromolar range would also suggest that the quinonoid 
equilibrium is more favourable than internal/external aldimine formation. This would confirm the theory 
that the quinonoid generally is in fast equilibrium with its precursor aldiniine, an observation 
substantiated by the activity of A.aeolicus AONS at high temperature, which fails to display a visible 
quinonoid with larger concentrations of L-alanine. 
The absence of a visible quinonoid after titration of the mutant protein Hi 1 8F/AONS with L-alanine 
would suggest that removal of the histidine residue reduces the thermodynamic favourability of 
quinonoid formation. However, kinetic assays confirm that C 2 proton abstraction and thioester bond 
cleavage must occur within the active site as an activity can be measured for the mutant enzyme. This 
activity is reduced, however, and possible misalignment of the cofactor, which hinders displacement of 
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the active site lysine residue by the incoming amino acid substrate, may be the cause. Subsequent 
reaction with the second substrate is thus also reduced. 
The increased affinity of A. aeolicus AONS for its cofactor already suggests a change in the configuration 
of the active site to favour retention of PLP. A serine residue is apparent at position 222 in the sequence. 
The corresponding residue in E.coli is glycine 235 and it has already been established that PLP binding 
to this enzyme is much weaker than its thermophilic counterpart. Comparison of cofactor binding 
observed in the HF mutants of both E.coli and A.aeolicus enzymes would also suggest a further 
stabilising factor present in the active site of the heat stable protein. Sequence alignment suggests that 
this residue may be either a glycine or a serine. Both are aliphatic residues, but serine contains a 
hydroxyl group. As this residue is adjacent to the crucial lysine residue responsible for cofactor binding 
(see section 1.2.1), it is possible that it forms an hydrogen bond with the phosphate of the PLP cofactor, 
thus stabilising it further in the active site. Comparison of all AONS sequences known with established 
evolutionary patterns (199) would suggest that the serine/phenylalaninelaspartate active site, as seen in 
A.aeolicus and Methanococcus jannaschii, combination evolved first. The initial change to this group 
was possibly the phenylalanine/tyrosine switch in the contributory opposite monomer. The greatest 
flexibility is indicated for the acidic residues aspartate and glutamate, although it is unclear when these 
changes occurred. However, the serine/aspartate and glycine/glutamate combinations seem to be favoured 
(see Appendix I). The C-terminal region, corresponding to the area of conformational change observed 
in E.coli AONS on binding of the product (AON) to the cofactor, is well conserved throughout all 
species. 
Many extremophiles belong to Archea (143) (199) and only a few to the genera of Eubacteria. A.aeolicus 
is only the second genome of an eubacterial hyperthermophile to be completely sequenced 
(www.ebi.ac.uk/genomesl) . To date there have been few studies on hyperthemophilic PLP dependent 
enzymes from Eubacteria. Initial observations of the A.aeolicus enzyme have indicated that the catalytic 
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mechanism is similar to that previously established, but the real difference lies in the ability of the 
enzyme to function at 80°C, although how this is achieved is still unclear. A strategy common to 
temperature stability in proteins is an increase in ion pair networks (152) (173) and the fact that one 
third of the A.aeolicus AONS enzyme sequence, (compared to one fifth in the E.coli protein) is 
composed of charged residues suggests this may be a strategy for temperature stability in this protein. 
The unrefined structure already suggests tighter packing of some a-helices within the protein, and a 
reduced N-terminal region compared to E.coli and B.sphaericus proteins. It is already established that 
glutamine and asparagine residues are replaced by glutamate and aspartate residues in heat stable 
proteins. The conservation of both asparagine residues within the active site of AONS suggests that they 
are vital for activity of the enzyme. Modelling in the E.coli enzyme (36) has already indicated that N47 
is necessary for stabilising the first quinonoid intermediate, thus it may not be unreasonable to suggest 
that the second asparagine residue (NI 12 in E.coli) is also involved in the thermodynamic stability of 
AONS catalysis. Further comparison must await final refinement of the A. aeolicus structure. 
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- 	 - - - - 	 Bacillus halodurans 
Haemophillus influenzae 
Neisseria menninglidis 
Camp ylobacter jet uni 
- - 	 - Helicobacter pylon 
Staphylococcus epidermis (frag) 
- 	
Chlamvdia trachomatis 
L - Chlamydia pneumoniae 
Chlamvdia pneumoniae (BioF2) 
Evolutionary relationships between AONS proteins - amino acid count 
Aae Bhalo Bsp Bsu Cje Cpnl Cpn2 Ctr Eco Ehe Hin Hpy Mja Mie Mtu Nme Paer Sep Sma Sy 
Alanine 21 35 31 35 23 24 35 38 53 58 27 32 16 57 66 28 60 4 62 43 
Asparagine 9 14 14 15 19 12 17 10 8 5 20 20 22 3 4 19 8 13 9 16 
Cysteine 6 3 2 3 6 9 9 6 5 5 5 1 8 11 6 7 2 1 6 4 
Glutamine 5 14 10 13 9 11 21 21 27 24 25 11 3 7 10 23 13 13 27 18 
Glycine 26 33 36 31 15 23 21 26 32 35 19 17 29 38 38 22 44 5 38 39 
Isoleuclne 29 25 35 32 26 22 25 18 16 15 21 25 40 10 6 21 12 12 13 26 
Leucine 46 51 34 34 54 39 53 45 44 41 47 59 35 48 50 47 58 10 52 52 
Methionine 5 6 11 9 6 8 2 3 8 3 9 4 3 2 4 9 7 2 5 11 
Phenylalanine 15 11 18 16 31 20 16 20 11 11 20 26 18 6 7 22 12 9 8 12 
Prollne 9 15 9 13 7 13 9 10 14 14 15 12 9 16 19 15 18 3 14 24 
Serine 20 27 32 32 27 35 32 39 29 29 25 31 21 28 23 25 27 11 17 27 
Threonine 17 18 22 22 14 17 21 14 14 18 21 16 16 19 17 20 15 2 15 25 
Tryptophan 1 5 1 3 1 2 0 4 7 6 1 0 1 3 3 1 4 0 6 7 
Tyrosine 16 12 9 9 13 14 16 14 7 8 15 14 12 4 3 17 7 10 8 10 
Valine 23 24 21 25 11 28 15 30 25 26 21 14 24 47 42 19 26 8 18 22 
Aspartic acid 17 20 21 25 18 14 14 16 20 17 18 14 22 20 22 16 19 8 21 20 
Glutamic acid 42 28 28 19 32 22 21 20 17 20 22 22 32 19 16 20 24 6 15 18 
Arginine 21 25 18 21 12 13 20 18 28 31 22 9 15 30 37 25 29 2 38 24 
Histidine 7 14 7 14 13 29 22 14 12 12 10 13 10 12 9 8 12 1 7 19 
Lysine 38 15 30 18 43 15 13 11 7 7 17 33 36 5 4 16 4 6 3 20 
TOTAL 373 395 389 389 380 370 382 377 384 385 380 373 372 385 386 380 401 126 382 437 
Aae - Aquifex aeolicus 
Bhaol - Bacillus halodurans 
Bsp - Bacillus sphaericus 
Bsu - Bacillus subtillis 
Cje - Campylobacter juni 
Cpnl - Chlamydia pneumoniae bioFi 
Cpn2 - Chlamydia pneumoniae bioF2 
Ctr - Chiamydia trachomatis 
Abbrev latons 
Eco - Escherichia coli 
Ehe - Erwinia herbicola 
Hin - Haemophilus influenzae 
Hpy - Helicobacter pylon 
Mja - Methanococcus jarinaschli 
Mie - Mycobacterium leprae 
Mtu - Mycobacterium tuberculosis 
Nme - Neisseria menningtidis 
Paer - Pseudomonas aeruginosa 
Sma - Serratia marcescens 
Sy - Synechocystis PCC 6803 
Sep - Staphylococcus epidermis (f rag) 
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Appendix II 
Mechanistic Studies Of 8-Ainino-7-Oxononanoate Synthase. 
Scott P. Webster'*,  Dmitriy Alexeev2 , Dominic J. Campopiano', Lisa J. Mullan', Lindsay 
Sawyer2, Robert. L. Baxter'. 
'Edinburgh Centre for Protein Technology, Department of Chemistry, University of 
Edinburgh, West Mains Road, Edinburgh E119 3JJ, UK and 2 Structural Biochemistry 
Group, University of Edinburgh, Swann Building, Mayfield Road, Edinburgh, EH9 3JR, 
UK. 
Summary 
8-amino-7-oxononanoate synthase is a pyridoxal 5'-phosphate-dependent enzyme which 
catalyses the decarboxylative condensation of L-alanine with pimeloyl-CoA to form 8-
arnino-7-oxononanoate. Individual steps in the reaction mechanism of Escherichia co/i 
AONS have been probed by spectroscopy, pre-steady state kinetics and crystallography. 
Our results suggest that conformational transitions, induced by substrate and product 
binding, play an important role in catalysis. 
Introduction. 
The biotin biosynthetic pathway is an essential metabolic pathway found only in plants 
and microorganisms, making it an attractive target for herbicide and antibiotic 
development. In Escherichia coli, the first committed step in the biosynthesis of biotin is 
catalysed by the pyridoxal 5'-phosphate-dependent enzyme 8-amino-7-oxononanoate 
synthase (AONS) (1). This involves the decarboxylative condensation of pimeloyl-CoA 
and L-alanine to produce 8-amino-7-oxononanoate (AON), coenzyme A and carbon 
dioxide (Figure 1). 
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FIGURE 1. Reaction catalysed by AONS. 
0 
H3CCO2  + ccs _ 0 
NH3 
- H3C (ll —CO2 
NH3 
+ COASH + CO2 
The structure and overall reaction mechanism of AONS places it in the a-family of 
PLP-dependent enzymes (2). Alignment of the amino acid sequence of AONS with the 
enzymes of the a-oxoamine synthase family - 5-aminolevulinate synthase, serine 
palmitoyltransferase and 2-amino-3-oxobutyrate CoA ligase - shows that almost all of the 
active site residues are conserved within this family of enzymes (3). The overall tertiary 
fold of AONS is closest to that of dialkyiglycine decarboxylase although they have 
negligible amino acid sequence identity (4). The PLP cofactor is covalently bound to 
Lys236 through an imine linkage and interacts with two other basic residues, His 13 3  and 
His207, which may play an important role in substrate binding and catalysis (3). 
TABLE 1: Kinetic parameters for AONS. 
pimeloyl-CoA 	 L-alanine 
kcat 	 Km kat/Km Km kat/Km k 1 
(s) QiM) (Ivf's) (mlvi) (IVf's) (M's) 
0.06(0.01) 	25(2) 2400(430) 0.50(0.04) 120(21) 20000(6000) 
The steady state kinetic parameters for AONS exhibit no metal ion dependence, and are 
comparable to those of other a-oxoamine synthases (Table 1) (5). Although the kinetic 
mechanism of AONS has not been investigated in detail, it is thought to adhere to an 
ordered bi-bi model in which L-alanine binds to the enzyme active site before pimeloyl- 
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CoA (6). In common with the mechanisms of other PLP-dependent enzymes, the initial 
step of the AONS catalysed reaction involves displacement of the internal aldimine 
complex by the incoming amino acid substrate to form an external aldimine. This is 
followed by heterolytic cleavage of the Ca—H bond of the amino acid leading to a 
resonance stabilised quinonoid intermediate (7). This quinonoid is thought to react 
subsequently with the other substrate, pimeloyl-CoA, in a Claisen-type condensation to 
form a putative 3-ketoacid aldimine intermediate. Decarboxylation of the resultant - 
ketoacid presumably occurs to generate a second quinonoid intermediate, which is then 
protonated at C8 to form a product external aldimine. Finally, product release leads to 
regeneration of the internal aldimine with Lys236. 
Here we report a study of the interaction of AONS with its substrates and product, and 
suggest a mechanistic pathway in which conformational transitions of the enzyme play a 
critical catalytic role. This mechanism may prove to be common to all four enzymes of 
the a-oxoamine synthase family. 
Materials and Methods 
Protein characterisation. Purification of AONS and determination of steady state 
kinetic parameters were carried out as described previously (3). 
Spectroscopic methods. All UV-visible spectra were recorded on a Hewlett-Packard 
8452A diode array spectrophotometer. The AONS concentration in all analyses was 
10p.M in 20mM potassium phosphate (pH 7.5). Reference cuvettes contained all other 
components except AONS. 
Pre-steady state kinetics. Transient absorption kinetics were determined under pseudo-
first order conditions using an Applied Photophysics SX 17 stopped-flow 
spectrophotometer, thermostatically controlled at 30°C. For the determination of rates of 
formation of external aldimine, syringes contained 20J.LM AONS and 0-100mM L- or D-
alanine. Spectra were recorded at 425nm and fitted to single exponential saturation 
,1frftecd 'iT 
curves. Rate constants were determined from the slope of a best-fit line produced from a 
plot of observed rate constant versus alanine concentration. For analysis of quinonoid 
formation, one syringe contained 25p.M AONS pre-equilibrated with 10mM L-alanine 
and the other 0-300p.M pimeloyl-CoA. Spectra were recorded at 486nm and the separate 
phases fitted to single exponential curves. 
Determination of dissociation constants. Enzyme samples were dialysed overnight in 
20mM potassium phosphate (pH 7.5) containing 100tM PLP. Non-enzyme bound PLP 
was removed by multiple washes with 20mM potassium phosphate through a Centrex 
UF2 concentrator (Schleicher & Schuell). Assays typically contained 10-50mM AONS in 
20mM potassium phosphate (pH 7.5) with varying amounts of L- or D-alanine (0-
80mM). Pimeloyl-CoA (143mM) was included where required. After addition of 
substrate, the reactants were mixed and allowed to equilibrate for 20mins at 30°C. 
Spectra were recorded and changes in absorbance at 425nm plotted against L- or D-
alanine concentration. Data were fitted to a hyberbolic saturation curve using the 
equation, AA.S/K1+S where AA is the maximal absorbance change, S is the 
L- or D-alanine concentration, and Kd is the dissociation constant. 
Crystallography. Crystals of AONS were grown as previously described (3). X-ray 
diffraction data of crystals containing AON was collected to a resolution of 2.OA (D. 
Alexeev, personal communication). 
Results and Discussion. 
Substrate external aldimine formation. The absorbance spectrum of AONS holo-
enzyme shows peaks at 334nm and 425nm which we assign to the non-coplanar and 
coplanar forms of the AONS-PLP internal aldimine (Figure 2). Addition of L- or D-
alanine to AONS leads to an increase in the absorbance of the 425nm band indicating 
formation of an external aldimine. The pre-steady state rate constant, k 1 , for L-alanine 











substrate. If an ordered bi-bi mechanism is assumed we would expect k1 to approximate 
kcat/Km for L-alanine (6). The fact that kcat/Km is less than k1 for L-alanine suggests that 
there may be a slow step following external aldimine formation that is necessary for 
productive binding of pimeloyl-CoA. 
FIGURE 2: Changes in cofactor absorbance spectra. (A) AONS (solid line), AONS + L- 
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The equilibrium between internal and external aldimine forms of AONS is affected by 
the presence of pimeloyl-00A. A plot of absorption increase at 425nm versus L-alanine 
concentration gives a curve with dissociation constant, Kd=0.9mM, while titration of 
AONS with D-alanine gives a K=9.8niM (Figure 3). In the presence of saturating 
amounts of pimeloyl-CoA, titration of AONS with D-alanine leads to a more than two-
fold decrease in the dissociation constant (Kd=4.5mM). A decrease in the dissociation 
constant (Kd=0.3mM) of L-alanine in the presence of pimeloyl-CoA is also observed 
(data obtained from reciprocal plots of steady state kinetic data). Although we have no 
direct structural evidence, we speculate that the dissociation constant is reduced by 
binding of pimeloyl-CoA, which blocks the exit path of the amino acid substrate from the 
bottom of the binding site. Additionally, it is also conceivable that pimeloyl-CoA induces 















FIGURE 3: Binding of L-alanine to AONS. (A) Absorbance spectra in presence of L-
alanine (from bottom to top 0, 0. 1, 0.5, 1, 2, 5, 10, 15 and 20mM), (B) plot of 
absorbance versus titrant concentration. 
0.030 




Addition of L- or D-alanine to AONS does not lead to quinonoid formation as 
indicated by the absence of a band at longer wavelength in the absorbance spectrum 
(Figure 2). It therefore seems likely that binding of L-alanine alone is insufficient to 
promote significant proton abstraction at Ca and leads to a benign form of the external 
aldimine-enzyme complex. The L-alanine external aldimine complex has not yet been 
crystallised, but has been modelled by analogy with the product aldimine structure (Figure 
4). A probable interaction (analogous to the C7 carbonyl interaction in the product 
aldimine structure) between a carboxylate oxygen of the L-alanine-PLP complex and 
His133 places the Ca hydrogen away from the catalytic Lys236, making reaction with 
Lys236 unlikely. Proton abstraction would thus require a rotation around the N-Ca bond 
in the pyridine plane, which would direct the Ca hyrogen towards Lys236. Such a 
rotation would place the Ca carboxylate, previously interacting with His133, within 
hydrogen bonding distance of the side chain of Asn47, and thus generating a stable 
external aldimine complex. 
Reaction with pimeloyl-00A. In addition to enhancing the binding of L-alanine to 
AONS, addition of pimeloyl-CoA to the pre-formed external aldimine complex leads to 
formation of a quinonoid intermediate (Figure 2). Pre-steady state kinetic experiments 
revealed that the formation of this intermediate (k=45s') is preceded by a distinct lag 
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phase (-'30ms). It is likely that this lag represents conformational transitions of the 
enzyme which place the Ca hydrogen of the L-alanine-PLP complex and the catalytic 
lysine in a favourable orientation for catalysis. Modelling suggests that docking of 
pimeloyl-CoA in the active site may lead to displacement of the carboxylate oxygen of L-
alanine from His 13 3  which then forms a hydrogen bond with Asn47. This new orientation 
of the external aldimine places the Ca proton close to Lys236 in a position perpendicular 
to the pyridine ring leading to cleavage of the Ca-H bond in accordance with Dunathan's 
hypothesis (8). Following this pimeloyl-CoA-induced Ca deprotonation, the quinonoid is 
free to attack the thioester carbonyl of pimeloyl-00A liberating coenzymeA and 
producing a -ketoacid-aldimine complex. At present, little is known about the 
mechanism of decarboxylation of the 3-ketoacid, but our results suggest it is likely to 
lead to formation of a second quinonoid intermediate (Figure 2). 
Interaction with AON. In solution, incubation of AONS holo-enzyme with the product 
of the reaction, AON, gives rise to a spectrum with maxima at 436nm and 520nm (Figure 
2). It is likely that these bands reflect the equilibrium between the external aldimine and 
quinonoid forms of the product complex respectively. The quinonoid form has an 
absorption maximum at a substantially longer wavelength than the substrate-PLP 
quinonoid formed earlier in the catalytic pathway and probably arises from the 
decarboxylation of the putative -ketoacid described above. 
The structure of AONS incubated with its product, AON, has been determined to 2.OA 
resolution. In contrast to the equilibrium between quinonoid and aldimine forms existing 
in solution, only the aldimine form is observed in the crystal. The N8C4A double bond 
of the AON-PLP complex is coplanar with the pyridine ring while the C7 carbonyl 
oxygen of the complex is hydrogen bonded to His 133. The carboxylate of AON is bound 
to Arg2l from the N-terminal domain and Arg349 from the C-terminal domain of the 
enzyme. A magnesium ion is coordinated to 03, N8, the hydroxyl of Ser179 and two 
water molecules. Since the enzymatic activity of AONS exhibits no magnesium 
,lfrfte#cdv '1'? 
dependence it is unlikely that the ion plays a role in catalysis and may have arisen from 
trace ions present in the crystallisation buffer. 
FIGURE 4: Cofactor binding site. PLP internal aldimine (left) and AON-PLP external 
aldimine (right). 
C-terminal domain movement. The overall refined protein structure of the AON-
enzyme complex is close to that of the holo-enzyme. However, the n-sheet of the C-
terminal domain undergoes a conformational transition whereby three n-strands of this 
flexible domain fold towards the active site of the AONS catalytic dimer (Figure 5). This 
movement narrows the access to the binding site and may be analogous to the apparent 
transition, which occurs upon binding of pimeloyl-00A to the pre-formed substrate 
external aldimine complex. The release of this structural cap over the active site must be 
reversed upon product release and concomitant reformation of the internal aldimine. The 
energy barrier for this process is likely to be large and it may represent the rate 
determining step in the enzymatic reaction, since neither substrate external aldimine 
formation or quinonoid formation approximate kcat. 
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FIGURE 5: Conformational changes in AONS structure. 
Conclusion. These results suggest a mechanistically reasonable pathway for the 
catalytic action of AONS, which may prove common for other members of the a-
oxoamine family of enzymes. Further studies will shed light on the role of active site 
residues in the catalytic reaction and may explain the involvement of conformational 
changes in the protein during catalysis. 
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Purification of E.coli AONS 
The E.coli AONS protein, induced with 1mM LPTG, is easily distinguished from the background 
expression as a large band visible on an SIDS polyacrylamide gel at 42kDa in figure 111-1. The over-
expression plasmid was pETl6bfbioF transformed into E.coli HMS 174 cells. 
Figure Ill-I 
Over-expression of E.coIiAONS as seen after mini-induction (see section 2.2.1). Lane 1 - Standards; 
Lane 2 - Uninduced cells; Lane 3 - Induced cells; Lane 4 - Uninduced cells; Lane 5 - Induced cells. 
Standards are: Phosphorylase b (97kDA); Albumin (66kDa); Ovalbumin (45kDa); Carbonic anhydrase 
(30kDA); Trypsin inhibitor (20.10a); ci-lactalbumin (14.4kDa) 
The induced cell culture was harvested and after sonication and ammonium sulphate fractionation 
the protein solution was passed down a Phenyl sepharose column (see section 2.2). Fractions 
containing AONS eluted at 3% ammonium sulphate and were visible as large bands on an SDS 
polyacrylamide gel (see figure 111-2). 





Elution of E.coli AONS after hydrophobic interaction chromatography (see section 2.2.5). Lane 1 - 
Standards; Lanes 3 —10 show fractions containing AONS. Standards are: Phosphorylase b (97kDA); 
Albumin (66kDa); Ovalbumin (45kDa); Carbonic anhydrase (30kDA); Trypsin inhibitor (20.1kDa); a-
lactalbumin (14.4kDa) 
The final step of purification involves anion exchange chromatography. The pooled AONS fractions 
from the previous chromatographic step are passed down a Q-sepharose column with a 0-IM NaCl 




Elution of E.coli AONS after hydrophobic interaction chromatography (see section 2.2.5). Lane 1 - 
Standards; Lanes 2 —8 show fractions containing AONS at 95% purity. Standards are: Phosphorylase 
b (97kDA); Albumin (66kDa); Ovalbumin (45kDa); Carbonic anhydrase (30kDA); Trypsin inhibitor 
(20.1kDa); a-lactalbumin (14.4kDa) 
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